Naar www.iknl.nl
- Gastroenterologie > Erfelijke darmkanker
Notificatie richtlijn E-mail richtlijn Naar startpagina oncoline
----------

Laatst gewijzigd : 2015-12-31, Versie: 2.0, Verantwoording: VKGN, Type: Landelijke richtlijn

Referentielijst

1 - Aarnio M (1999)
Aarnio M, Sankila R, Pukkala E, Salovaara R, Aaltonen LA, de la Chapelle A et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 1999;81:214-8.
 
2 - Acheson LS (2000)
Acheson LS, Wiesner GL, Zyzanski SJ, Goodwin MA, Stange KC. Family history-taking in community family practice: implications for genetic screening. Genet Med. 2000;2:180-5.
 
3 - Aerts MCM (2007)

Aerts MCM, Popma JR. Erfelijke borst- of darmkanker en verzekerbaarheid. Onderzoek in opdracht van Breed Platform Verzekerden en Werk. Universiteit van Amsterdam, 2007.

 
4 - Aktan-Collan K (2000)
Aktan-Collan K, Mecklin JP, Järvinen H, Nystrom-Lahti M, Peltomäki P, Soderling I et al. Predictive genetic testing for hereditary non-polyposis colorectal cancer: uptake and long-term satisfaction. Int J Cancer 2000; 89: 44-50.
 
5 - American Gastroenterological Association (2001)

American Gastroenterological Association. Medical position statement: Hereditary colorectal cancer and genetic testing. Gastroenterology 2001:121:195-7.

 
6 - Anwar S (2000)
Anwar S, Hall C, White J, Deakin M, Farrell W, Elder JB. Hereditary non-polyposis colorectal cancer: an updated review. Eur J Surg Oncol. 2000;26:635-45.
 
7 - Aoun E (2005)
Aoun E, bdul-Baki H, Azar C, Mourad F, Barada K, Berro Z et al. A randomized single-blind trial of split-dose PEG-electrolyte solution without dietary restriction compared with whole dose PEG-electrolyte solution with dietary restriction for colonoscopy preparation. Gastrointest Endosc 2005;62:213-8.
 
8 - Apse KA (2004)

Apse KA, Biesecker BB, Giardiello FM, Fuller BP, Bernhardt BA. Perceptions of genetic discrimination among at-risk relatives of colorectal cancer patients. Genet Med 2004;6:510-6.

 
9 - Aretz S (2006)

Aretz S, Uhlhaas S, Goergens H, Siberg K, Vogel M, Pagenstecher C et al. MUTYH associated polyposis: 70 of 71 patients with biallelic mutations present with an attenuated or atypical phenotype. Int J Cancer 2006;119:807-14.

 
10 - Arrigoni A (2005)
Arrigoni A, Sprujevnik T, Alvisi V, Rossi A, Ricci G, Pennazio M et al. Clinical identification and long-term surveillance of 22 hereditary non-polyposis colon cancer Italian families. Eur J Gastroenterol Hepatol 2005;17:213-9.
 
11 - Aronchick CA (2000)
Aronchick CA, Lipshutz WH, Wright SH, Dufrayne F, Bergman G. A novel tableted purgative for colonoscopic preparation: efficacy and safety comparisons with Colyte and Fleet Phospho-Soda. Gastrointest Endosc 2000;52:346-52.
 
12 - Arvanitis ML (1990)
Arvanitis ML, Jagelman DG, Fazio VW, Lavery IC, McGannon E. Mortality in patients with familial adenomatous polyposis. Dis Colon Rectum 1990;33:639-42.
 
13 - Arver B (2004)
Arver B, Haegermark A, Platten U, Lindblom A, Brandberg Y. Evaluation of psychosocial effects of pre-symptomatic testing for breast/ovarian and colon cancer pre-disposing genes: a 12-month follow-up. Fam Cancer 2004;3:109-16.
 
14 - ASCO (2003)

(ASCO) American Society of Clinical Oncology Policy Statement Update: Genetic Testing for Cancer Susceptibility. J Clin Oncol 2003:21; 2397-2406.

 
15 - Attanoos R (1995)
Attanoos R, Billings PJ, Hughes LE, Williams GT. Ileostomy polyps, adenomas, and adenocarcinomas. Gut 1995;37:840-4.
 
16 - Aziz O (2006)
Aziz O, Athanasiou T, Fazio VW, Nicholls RJ, Darzi AW, Church J et al. Meta-analysis of observational studies of ileorectal versus ileal pouch-anal anastomosis for familial adenomatous polyposis. Br J Surg 2006;93:407-17.
 
17 - Azizi L (2005)
Azizi L, Balu M, Belkacem A, Lewin M, Tubiana JM, Arrive L. MRI features of mesenteric desmoid tumors in familial adenomatous polyposis. Am J Roentgenol. 2005;184:1128-35.
 
18 - Baglietto L (2006)
Baglietto L, Jenkins MA, Severi G, Giles GG, Bishop DT, Boyle P et al. Measures of familial aggregation depend on definition of family history: meta-analysis for colorectal cancer. J Clin Epidemiol 2006;59:114-24.
 
19 - Bandipalliam P (2005)
Bandipalliam P. Syndrome of early onset colon cancers, hematologic malignancies & features of neurofibromatosis in HNPCC families with homozygous mismatch repair gene mutations. Fam Cancer 2005;4: 323-33.
 
20 - Barclay RL (2004)
Barclay RL. Safety, efficacy, and patient tolerance of a three-dose regimen of orally administered aqueous sodium phosphate for colonic cleansing before colonoscopy. Gastrointest Endosc 2004;60:527-33.
 
21 - Batra S (2002)
Batra S, Valdimarsdottir H, McGovern M, Itzkowitz S, Brown K. Awareness of genetic testing for colorectal cancer predisposition among specialists in gastroenterology. Am J Gastroenterol. 2002;97:729-33.
 
22 - Begg CB (2002)
Begg CB. On the use of familial aggregation in population-based case probands for calculating penetrance. J Natl Cancer Inst 2002;94:1221-6.
 
23 - Berkelhammer C (2002)
Berkelhammer C, Ekambaram A, Silva RG. Low-volume oral colonoscopy bowel preparation: sodium phosphate and magnesium citrate. Gastrointest Endosc 2002;56:89-94.
 
24 - Bernstein L (2006)
Bernstein L. The risk of breast, endometrial and ovarian cancer in users of hormonal preparations. Basic Clin Pharmacol Toxicol. 2006;98:288-96.
 
25 - Bertario L (2000)
Bertario L, Russo A, Radice P, Varesco L, Eboli M, Spinelli P et al. Genotype and phenotype factors as determinants for rectal stump cancer in patients with familial adenomatous polyposis. Hereditary colorectal tumors registry. Ann Surg 2000;231:538-43.
 
26 - Bertario L (2001)
Bertario L, Russo A, Sala P,Eboli M, Giarola M, D'amico F et al. Genotype and phenotype factors as determinants of desmoid tumours in patients with familial adenomatous polyposis. Int J Cancer 2001;95:102-7.
 
27 - Biesecker BB (1997)

Biesecker BB. Psychological issues in cancer genetics. Semin Oncol Nurs 1997;13:129-34.

 
28 - Bijlsma EK (2005)
Bijlsma EK, Oosterwijk JC, Leschot NJ. Leerboek Medische Genetica. red. zevende druk, Elsevier gezondheidszorg, Maarssen, 2005.
 
29 - Björk J (2001)
Björk J, Akerbrant H, Iselius L, Bergman A, Engwall Y, Wahlstrom J et al. Periampullary adenomas and adenocarcinomas in familial adenomatous polyposis: cumulative risks and APC gene mutations. Gastroenterology 2001;121:1127-35.
 
30 - Bleiker EM (2001)
Bleiker EM, Grosfeld FJ, Hahn DE, Honing C. Psychosocial care in family cancer clinics in the Netherlands: a brief report. Patient Educ Couns 2001;43:205-9.
 
31 - Bleiker EMA (2003)
Bleiker EMA, Hahn DE, Aaronson NK. Psychosocial issues in cancer genetics. Acta Oncol 2003;42:276-86.
 
32 - Bleiker EMA (2005)
Bleiker EMA, Menko FH, Taal BG, Kluijt I Wever LD, Gerritsma MA et al. Screening behavior of individuals at high risk for colorectal cancer. Gastroenterology 2005;128:280-7.
 
33 - Boland CR (2005)
Boland CR. Evolution of the nomenclature for the hereditary colorectal cancer syndromes. Fam Cancer 2005;4:211-8.
 
34 - Bonelli L (1988)
Bonelli L, Martines H, Conio M, Bruzzi P, Aste H. Family history of colorectal cancer as a risk factor for benign and malignant tumours of the large bowel. A case-control study. Int J Cancer 1988;41:513-7.
 
35 - Boutron MC (1995)
Boutron MC, Faivre J, Quipourt V, Senesse P, Michiels C. Family history of colorectal tumours and implications for the adenoma-carcinoma sequence: a case control study. Gut 1995;37:830-4.
 
36 - Bradshaw N (2003)
Bradshaw N, Holloway S, Penman I, Dunlop MG, Porteous ME. Colonoscopy surveillance of individuals at risk of familial colorectal cancer. Gut 2003;52:1748-51.
 
37 - Bright-Thomas RM (2002)
Bright-Thomas RM, Agrawal A, Hargest R. Preclinical studies of gene transfer for the treatment of desmoid disease in familial adenomatous polyposis. Br J Surg 2002;89:1563-9.
 
38 - Brooker JC (2002)
Brooker JC, Saunders BP, Shah SG, Thapar CJ, Thomas HJ, Atikin WS et al. Total colonic dye-spray increases the detection of diminutive adenomas during routine colonoscopy: a randomized controlled trial. Gastrointest Endosc 2002;56:333-8.
 
39 - Brosens LAA (2005)
Brosens LAA, Keller JJ, Offerhaus GJA, Goggins M, Giardiello FM. Prevention and management of duodenal polyps in familial adenomatous polyposis. Gut 2005;54:1034-43.
 
40 - de Bruin JH (2005)
de Bruin JH, Kievit W, Ligtenberg MJ, Nagengast FM, Adang EM, Ruers TJ et al. Meer opsporing van erfelijke darmkanker met onderzoek op microsatellietinstabiliteit bij door de patholoog geselecteerde patiënten met een colon-rectumcarcinoom. Ned Tijdschr Geneeskd. 2005;149:1792-8.
 
41 - Bülow S (1987)
Bülow S. Familial polyposis coli. Dan Med Bull 1987;34:1-15.
 
42 - Bülow S (1995)
Bülow S, Bülow C, Nielsen TF, Karlsen L, Moesgaard F. Centralized registration, prophylactic examination, and treatment results in improved prognosis in familial adenomatous polyposis. Results from the Danish Polyposis Register. Scand J Gastroenterol 1995;30:989-93.
 
43 - Bülow S (2003)
Bülow S. Results of national registration of familial adenomatous polyposis. Gut 2003;52:742-6.
 
44 - Bülow S (2004)
Bülow S, Bjork J, Christensen IJ, Fausa O, Järvinen H, Moesgaard F et al. Duodenal adenomatosis in familial adenomatous polyposis. Gut 2004;53:381-6.
 
45 - Burke W (1997)
Burke W, Petersen G, Lynch P, Botkin J, Daly M, Garber J et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium. JAMA 1997;277:915-9.
 
46 - Burke W (2006)
Burke W, Press N. Ethical obligations and counseling challenges in cancer genetics. J Natl Compr Canc Netw 2006;4:185-91.
 
47 - Burke W (2006)
Burke W. Press N. Genetics as a tool to improve cancer outcomes: ethics and policy. Nature Rev Cancer 2006;6:476-82.
 
48 - Burt RW (2000)
Burt RW. Colon cancer screening. Gastroenterology 2000 Sep;119:837-53.
 
49 - Burt RW (2004)
Burt RW, Leppert MF, Slattery ML, Samowitz WS, Spirio LN, Kerber RA et al. Genetic testing and phenotype in a large kindred with attenuated familial adenomatous polyposis. Gastroenterology 2004;127:444-51.
 
50 - Butterworth AS (2006)
Butterworth AS, Higgins JP, Pharoah P. Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis. Eur J Cancer 2006;42:216-27.
 
51 - Bussey HJR (1975)
Bussey HJR. Familial polyposis coli. Family studies, Histopathology, Differential diagnosis, and Results of Treatment. Baltimore: Johns Hopkins University Press; 1975.
 
52 - Buttin BM (2004)
Buttin BM, Powell MA, Mutch DG, Babb SA, Huttner PC, Edmonston TB et al. Penetrance and expressivity of MSH6 germline mutations in seven kindreds not ascertained by family history. Am J Hum Genet 2004;74:1262-9.
 
53 - Carayol J (2002)

Carayol J, Khlat M, Maccario J, Bonaiti-Pellie C. Hereditary non-polyposis colorectal cancer: current risks of colorectal cancer largely overestimated. J Med Genet 2002;39:335-9.

 
54 - Carlsson AH (2004)
Carlsson AH, Bjorvatn C, Engebretsen LF, Berglund G, Natvig GK. Psychosocial factors associated with quality of life among individuals attending genetic counseling for hereditary cancer. J Genet Couns 2004;13:425-45.
 
55 - Carroll JC (1999)
Carroll JC, Heisey RE, Warner E, Goel V, MCCready DR. Hereditary breast cancer; psyhocosial issues and the physicians' role. Can Fam Phys 1999;45:126-32.
 
56 - De Castro SMM (2006)
De Castro SMM, Smeenk HG, Rutten JP, van Goor H, van Eijck CH, Busch ORC et al. Pancreas preserving total duodenectomy for patients with familial adenomatous polyposis of the duodenum: a comparison with standard pancreaticoduodenectomy. Abstract NVGE voorjaarsvergadering 2006
 
57 - Cederquist K (2005)
Cederquist K, Emanuelsson M, Wiklund F, Golovleva I, Palmqvist R, Grönberg H. Two Swedish founder MSH6 mutations, one nonsense and one missense, conferring high cumulative risk of Lynch syndrome. Clin Genet 2005;68:533-41.
 
58 - De la Chapelle A (2004)
De la Chapelle A. Genetic predisposition to colorectal cancer. Nature Rev. Cancer 2004; 4:769-79.
 
59 - Chen LM (2007)
Chen LM, Yang KY, Little SE, Cheung MK, Caughey AB. Gynecologic cancer prevention in Lynch syndrome/HNPCC families. Obstet Gynecol 2007;110:18-25.
 
60 - Chow E (2004)
Chow E, Thirlwell C, MaCrae F, Lipton L. Colorectal cancer and inherited mutations in base-excision repair. Lancet Oncol 2004;5:600-6.
 
61 - Church J (2001)
Church J, Burke C, McGannon E, Pastean O, Clark B. Predicting polyposis severity proctoscopy: How reliable is it? Dis Colon Rectum 2001;44:1249-54.
 
62 - Church J (2003)
Church J, Burke C, McGannon E, Pastean O, Clark B. Risk of rectal cancer after colectomy and ileorectal anastomosis for familial adenomatous polyposis : A function of available surgical options. Dis Colon Rectum 2003;46:1175-81.
 
63 - Church J (2003)
Church J, Simmang C. Standards task Force of the American Society of Colon and Rectal Surgeons. Practice parameters for treatment of patients with predominantly colorectal cancer (Familial Adenomatous Polyposis and Hereditary Nonpolyposis Colorectal Cancer). Dis Colon Rectum 2003;46:1001-12.
 
64 - Church J (2006)
Church J. In which patients do I perform IRA, and why? Fam. Cancer 2006;5:237-40.
 
65 - Cibula DA (2003)
Cibula DA, Morrow CB. Determining local colorectal cancer screening utilization patterns. J Public Health Manag Pract 2003;9:315-21.
 
66 - Claes E (2005)
Claes E, Denayer L, Evers-Kiebooms G, Boogaerts A, Philippe K, Teipar S et al. Predictive testing for hereditary non-polyposis colorectal cancer: subjective perception regarding colorectal and endometrial cancer, distress and health-related behaviour one year post-test. Genet Test 2005;9:54-65.
 
67 - Clark SK (1996)
Clark SK, Phillips RKS. Desmoids in familial adenomatous polyposis. Br J Surg 1996;83:1494-504.
 
68 - Clark SK (1998)

Clark SK, Smith TG, Katz DE, Reznek RH, Phillips RK. Identification and progression of a desmoid precursor lesion in patients with familial adenomatous polyposis. Br J Surg 1998;85:970-3.

 
69 - Clark SK (1999)
Clark SK, Neale KF, Landgrebe JC, Phillips RK. Desmoid tumours complicating familial adenomatous polyposis. Br J Surg 1999;86:1185-9.
 
70 - Clark TW (2003)
Clark TW. Percutaneous chemical ablation of desmoid tumors. J Vasc Interv Radiol 2003;14:629-34.
 
71 - Clarke A (1998)
Clarke A. The Genetic Testing of Children. Oxford: BIOS Scientific Publishers Ltd, 1998.
 
72 - Cobben JM (2002)
Cobben JM, Bröcker-Vriends AHJT, Leschot NJ. Prenatale diagnostiek naar erfelijke aanleg voor mamma/ ovariumcarcinoom - een standpuntbepaling. Ned Tijdschr Geneeskd 2002;146:1461-5.
 
73 - Codori AM (2003)
Codori AM, Zawacki KL, Petersen GM, Miglioretti DL, Bacon JA, Trimbath JD et al. Genetic testing for hereditary colorectal cancer in children: long-term psychological effects. Am J Med Genet A 2003;116:117-28.
 
74 - De Cosse JJ (1992)
De Cosse JJ, Bülow S, Neale K, Järvinen HK, Alm T, Hultcrantz R et al. Rectal cancer risk in patients treated for familial adenomatous polyposis. Br J Surg 1992;79:1372-75.
 
75 - Couture J (2000)
Couture J, Mitri A, Lagace R, Smits R, Berk T, Bouchard HL et al. A germline mutation at the extreme 3' end of the APC gene results in a severe desmoid phenotype and is associated with overexpression of beta-catenin in the desmoid tumour. Clin Genet 2000; 57:205-12.
 
76 - Croyle RT (1999)
Croyle RT, Lerman C. Risk communication in genetic testing for cancer susceptibility. J Natl Cancer Inst Monogr 1999;25:59-66.
 
77 - Cruz -Correa M (2002)
Cruz-Correa M, Hylind LM, Romans K, et al. Long term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study. Gastroenterology 2002;122: 641-5.
 
78 - Cruz-Correa M (2003)
Cruz-Correa M, Giardiello FM. Familial adenomatous polyposis. Gastrointest Endosc 2003;58:885-94.
 
79 - Cummings S (2000)
Cummings S. The genetic testing process: how much counseling is needed? J Clin Oncol.2000;18(21Suppl):60s-64s.
 
80 - Cunningham JM (2001)
Cunningham JM, Kim CY, Christensen ER, Tester DJ, Parc Y, Burgart LJ et al. The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas. Am J Hum Genet. 2001;69:780-90.
 
81 - Van Dalen R (2003)
Van Dalen R, Church J, McGannon E, Fay S, Burke C, Clark B. Patterns of surgery in patients belonging to Amsterdam-positive families. Dis Colon Rectum 2003;46:617-20.
 
82 - Daly MB (2005)
Daly MB, Stearman B, Masny A, Sein E, Mazzoni S. How to establish a high-risk cancer genetics clinic: limitations and successes. Curr Oncol Rep 2005;7:469-74.
 
83 - Davey A (2005)
Davey A, Rostant K, Harrop K, Goldblatt J, O'Leary P. Evaluating genetic counseling: client expectations, psychological adjustment and satisfaction with service. J Genet Couns 2005;14:197-206.
 
84 - Dekker E (2006)
Dekker E, Dees J, Mathus-Vliegen L, Poley JW, Offerhaus J, Bartelsman J et al. High-resolution endoscopy and the additional values of chromo-endoscopy in the evaluation of duodenal polyposis in FAP-patients. Abstract NVGE voorjaarsvergadering 2006.
 
85 - Deng G (2004)
Deng G, Bell I, Crawley S, Gum J, Terdiman JP, Allen BA et al. BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer. Clin Cancer Res. 2004;10:191-5.
 
86 - DevCan (2005)
DevCan: Probability of Developing or Dying of Cancer Software, Version 6.1.1; Statistical Research and Applications Branch, National Cancer Institute, 2005. http://srab.cancer.gov/devcan.
 
87 - Domingo E (2004)
Domingo E, Laiho P, Ollikainen M, Pinto M, Wang L, French AJ et al. BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing. J Med Genet. 2004;41:664-8.
 
88 - Domingo E (2005)
Domingo E, Niessen RC, Oliveira C, Alhopuro P, Moutinho C, Espin E et al. BRAF-V600E is not involved in the colorectal tumorigenesis of HNPCC in patients with functional MLH1 and MSH2 genes. Oncogene 2005 2;24:3995-8.
 
89 - Dørum A (1999)
Dørum A, Heimdal K, Lovslett K, Kristensen G, Hansen LJ, Sandvei R et al. Prospectively detected cancer in familial breast/ovarian cancer screening. Acta Obstet Gynecol Scand 1999;78:906-11.
 
90 - Dove-Edwin I (2002)
Dove-Edwin I, Boks D, Goff S, Kenter GG, Carpenter R, Vasen HF et al. The outcome of endometrial cancer surveillance by ultrasound scan in women at risk of hereditary nonpolyposis colorectal carcinoma. Cancer 2002;94:1708-12.
 
91 - Dove-Edwin I (2005)
Dove-Edwin I, Sasieni P, Adams J, Thomas HJ. Prevention of colorectal cancer by colonoscopic surveillance in individuals with a family history of colorectal cancer: 16 year, prospective, follow-up study. BMJ 2005;331:1047.
 
92 - Dove-Edwin I (2006)
Dove-Edwin I, de Jong AE, Adams J, Mesher D, Lipton L, Sasieni P et al. Prospective results of surveillance colonoscopy in dominant familial colorectal cancer with and without Lynch syndrome. Gastroenterology 2006;130:1995-2000.
 
93 - Dunlop MG (1997)
Dunlop MG, Farrington SM, Carothers AD, Wyllie AH, Sharp L, Burn J, et al. Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet 1997;6:105-10.
 
94 - Durno C (2007)
Durno C, Monga N, Bapat B, Berk T, Cohen Z, Gallinger S. Does early colectomy increase desmoid risk in familial adenomatous polyposis. Clin Gastroenterol Hepatol. 2007;5:1190-4.
 
95 - Van Duijvendijk P (1999)
Van Duijvendijk P, Vasen HF, Bertario L, Bülow S, Kuijpers JH, Schouten WR et al. Cumulative risk of developing polyps or malignancy at the ileal pouch-anal anastomosis in patients with familial adenomatous polyposis. J Gastrointest Surg 1999;3:325-30.
 
96 - Van Duijvendijk P (1999)
Van Duijvendijk P, Slors JF, Taat CW, Oosterveld P, Vasen HF. Functional outcome after colectomy and ileorectal anastomosis compared to proctocolectomy and ileal pouch-anal anastomosis in familial adenomatous polyposis. Ann Surg 1999;230:648-54.
 
97 - Van Duijvendijk P (2000)
Van Duijvendijk P, Slors JF, Taat CW, Oosterveld P, Sprangers MA, Obertop H et al. Quality of life after total colectomy with ileorectal anastomosis or proctocolectomy and ileal pouch-anal anastomosis for familial adenomatous polyposis. Br J Surg 2000;87:590-6.
 
98 - El Sayed AM (2003)
El Sayed AM, Kanafani ZA, Mourad FH, Soweid AM, Barada KA, Adorian CS, et al. A randomized single-blind trial of whole versus split-dose polyethylene glycol-electrolyte solution for colonoscopy preparation. Gastrointest Endosc 2003 ;58:36-40.
 
99 - Emery J (1999)
Emery J, Watson E, Rose P, Andermann A. A systematic review of the literature exploring the role of primary care in genetic services. Fam Pract 1999;16:426-45. Review.
 
100 - Emery J (2001)
Emery J, Lucassen A, Murphy M. Common hereditary cancers and implications for primary care. Lancet 2001;358:56-63.
 
101 - Esplen MJ (2003)
Esplen MJ, Urquhart C, Butler K, Gallinger S, Aronson M, Wong J. The experience of loss and anticipation of distress in colorectal cancer patients undergoing genetic testing. J Psychosom Res 2003;55:427-35.
 
102 - van Everdingen JJE (2004)
van Everdingen JJE, Burgers JS, Assendelft WJJ et al. red. Evidence-based Richtlijnontwikkeling. Een Leidraad voor de Praktijk. Bohn, Stafleu, Van Loghum, Houten, 2004.
 
103 - Evidence-based Richtlijnonwikkeling (2005)
Evidence-based Richtlijnontwikkeling. Handleiding voor werkgroepleden, Kwaliteitsinstituut voor de Gezondheidszorg CBO, april 2005.
 
104 - Edwards AG (2006)
Edwards AG, Evans R, Dundon J, Haigh S, Hood K, Elwyn GJ. Personalised risk communication for informed decision making about taking screening tests. Cochrane Database Syst Rev 2006;4:CD001865.
 
105 - Fallowfield L (2001)
Fallowfield L, Ratcliffe D, Jenkins V, Saul J. Psychiatric morbidity and its recognition by doctors in patients with cancer. Br J Cancer 2001;84:1011-5.
 
106 - Fass R (1993)
Fass R, Do S, Hixson LJ. Fatal hyperphosphatemia following Fleet Phospo-Soda in a patient with colonic ileus. Am J Gastroenterol 1993;88:929-32.
 
107 - Finch A (2006)
Finch A, Beiner M, Lubinski J, Lynch HT, Moller P, Rosen B et al. Hereditary Ovarian Cancer Clinical Study Group. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation. JAMA 2006;296:185-92.
 
108 - Fiorentino F (2006)
Fiorentino F, Biricik A, Nuccitelli A, De Palma R, Kahraman S, Lacobelli M et al. Strategies and clinical outcome of 250 cycles of Preimplantation Genetic Diagnosis for single gene disorders. Hum Reprod 2006;21:670-84.
 
109 - Fornasarig M (2006)
Fornasarig M, Minisini AM, Viel A, Quaia M, Canzonieri V, Veronesi A. Twelve years of endoscopic surveillance in a family carrying biallelic Y165C MYH defect: report of a case. Dis Colon Rectum 2006;49:1-4.
 
110 - Friedman LC (1999)
Friedman LC, Webb JA, Richards CS, Plon SE. Psychological and behavioral factors associated with colorectal cancer screening among Ashkenazim. Prev Med 1999;29:119-25.
 
111 - Frommer D (1997)
Frommer D. Cleansing ability and tolerance of three bowel preparations for colonoscopy. Dis Colon Rectum 1997;40:100-4.
 
112 - Fry A (1999)
Fry A, Campbell H, Gudmunsdottir H, Rush R, Porteous M, Gorman D et al. GPs' views on their role in cancer genetics services and current practice. Fam Pract. 1999;16:468-74.
 
113 - Fuchs CS (1994)
Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Speizer FE, Willett WC. A prospective study of family history and the risk of colorectal cancer. N Engl J Med. 1994;331:1669-74.
 
114 - Gaarenstroom KN (2006)
Gaarenstroom KN, van der Hiel B, Tollenaar RA, Vink GR, Jansen FW, van Asperen CJ et al. Efficacy of screening women at high risk of hereditary ovarian cancer: results of an 11-year cohort study. Int J Gynecol Cancer 2006;16 Suppl 1:54-9.
 
115 - Galiatsatos P (2006)
Galiatsatos P, Foulkes WD. Familial adenomatous polyposis. Am J Gastroenterol 2006;101:385-98.
 
116 - Gallagher MC (2004)
Gallagher MC, Shankar A, Groves CJ, Russel RC, Phillips RK. Pylorus-preserving pancreaticoduodenectomy for advanced duodenal disease in familial adenomatous duodenal polyposis. Br J Surg 2004; 91:1157-64.
 
117 - Gallagher MC (2006)
Gallagher MC, Phillips RKS, Bulow S. Surveillance and management of upper gastrointestinal disease in Familial Adenomatous Polyposis. Fam Cancer 2006;5:263-73.
 
118 - Geirdal AO (2005)
Geirdal AO, Reichelt JG, Dahl AA, Heimdal K, Maehle L, Stormorken A et al. Psychological distress in women at risk of hereditary breast/ovarian or HNPCC cancers in the absence of demonstrated mutations. Fam Cancer 2005;4;121-6.
 
119 - McGettigan P (2006)
McGettigan P, Henry D. Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase. JAMA 2006;296:1633-44.
 
120 - Giardiello FM (1997)
Giardiello FM, Brensingen JP, Petersen GM, Luce MC, Hylind LM, Bacon JA et al. The use and interpretation of commercial APC genetic testing for familial adenomatous polyposis. N Engl J Med 1997;336:823-7.
 
121 - Giardiello FM (2001)
Giardiello FM, Brensinger JD, Petersen GM. AGA technical review on hereditary colorectal cancer and genetic testing. Gastroenterology 2001;121:198-213.
 
122 - Giardiello FM (2004)
Giardiello FM, Casero RA Jr, Hamilton SR, Hylind HMN, Trimbath JD, Geiman DE et al. Prostanoids, ornithine decarboxylase and polyamines in primary chemoprevention of familial adenomatous polyposis. Gastroenterology 2004;49:1259-61.
 
123 - Gigerenzer G (2003)
Gigerenzer G, Edwards A. Simple tools for understanding risks: from innumeracy to insight. BMJ 2003; 327:741-4.
 
124 - Gille JJP (2002)
Gille JJP, Hogervorst FBL, Pals G, Wijnen JT, Van Schooten RJ, Dommering CJ et al. Genomic deletions of MSH2 and Mlh1 in colorectal cancer families detected by a novel mutation detection approach. Br J Cancer 2002;87:892-7.
 
125 - Gismondi V (2004)
Gismondi V, Meta M, Bonelli O, Radice P, Sala P, Bertario L et al. Prevalence of the Y165C, G382D, and 1395delGGA germline mutations of the MYH gene in Italian patients with adenomatous polyposis coli and colorectal adenomas. Int J Cancer 2004;109:680-4.
 
126 - Godard B (2006)
Godard B, Hurlimann T, Letendre M, Egalite N, INHERIT BRCAs. Guidelines for disclosing genetic information to family members: from development to use. Fam Cancer 2006; 5: 103-16.
 
127 - Graham DJ (2005)
Graham DJ, Campen D, Hui R, Spence M, Cheetham C, Levy G et al. Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study. Lancet 2005;365:475-81.
 
128 - Grimes DA (1999)
Grimes DA, Snively GR. Patients' understanding of medical riks: implication for genetic counselling. Obstet. Gynaecol. 1999;93:910-4.
 
129 - Gritz ER (2005)
Gritz ER, Peterson SK, Vernon SW, Marani SK, Baile WF, Watts BG et al. Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer. J Clin Oncol 2005;23:1902-10.
 
130 - Grover S (2004)
Grover S, Stoffel EM, Bussone L, Tschoegl E, Syngal S. Physician assessment of family cancer history and referral for genetic evaluation in colorectal cancer patients. Clin Gastroenterol Hepatol 2004;2:813-9.
 
131 - Groves CJ (2002)
Groves CJ, Saunders BP, Spigelman AD, Phillips RK. Duodenal cancer in patients with familial adenomatous polyposis (FAP): results of a 10 year prospective study. Gut 2002;50:636-41.
 
132 - Guldenschuh I (2001)
Guldenschuh I, Hurlimann R, Muller A, Ammann R, Mullhaupt B, Dobbie Z et al. Relationship between APC genotype, polyp distribution and oral sulindac treatment in the colon and rectum of patients with familial adenomatous polyposis. Dis Colon Rectum 2001;44:1090-7.
 
133 - Gurbuz AK (1994)
Gurbuz AK, Giardiello FM, Petersen GM, Krush AJ, Offerhaus GJ, Booker SV et al. Desmoid tumours in familial adenomatous polyposis. Gut 1994;35:377-81.
 
134 - Haan M. de (1992)
Haan M de, Lisdonk E van de, Voorn TH. De Kern van de Huisartsgeneeskunde. Bunge Utrecht 1992.
 
135 - Habr-Gama A (1999)
Habr-Gama A, Bringel RW, Nahas SC, Araujo SE, Souza Junior AH, Calache JE et al. Bowel preparation for colonoscopy: comparison of mannitol and sodium phosphate. Results of a prospective randomized study. Rev Hosp Clin Fac Med Sao Paulo 1999;54:187-92.
 
136 - Hadley DW (2003)
Hadley DW, Jenkins J, Dimond E, Nakahara K, Grogan L, Liewehr DJ et al. Genetic counseling and testing in families with hereditary nonpolyposis colorectal cancer. Arch Intern Med 2003;163:573-82.
 
137 - Hadley DW (2004)
Hadley DW, Jenkins JF, Dimond E, De Carvalho M, Kirsch I, Palmer CG. Colon cancer screening practices after genetic counseling and testing for hereditary nonpolyposis colorectal cancer. J Clin Oncol 2004;22;39-44.
 
138 - Halbert CH (2004)
Halbert CH, Lynch H, Lynch J, Main D, Kucharski S, Rustgi AK et al. Colon cancer screening practices following genetic testing for hereditary nonpolyposis colon cancer (HNPCC) mutations. Arch Intern Med 2004;164:1881-7.
 
139 - Hampel H (2005)
Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 2005;352:1851-60.
 
140 - Hampel H (2005)
Hampel H, Stephens JA, Pukkala E, Sankila R, Aaltonen LA, Mecklin J-P et al. Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset. Gastroenterology 2005;129:415-21.
 
141 - Han J (2006)
Han J, Kim MH. Technical review: Endoscopic papillectomy for adenomas of the major duodenal papilla. Gastrointest Endosc 2006;633:292-301.
 
142 - Harris MA (1997)

Harris MA, Byles JE. A survey of screening compliance among first degree relatives of people with colon cancer in new south wales. J Med Screen 1997;4:29-34.

 
143 - Harris M (2005)
Harris M, Winship I, Spriggs M. Controversies and ethical issues in cancer-genetics clinics. Lancet Oncol 2005;6:301-10.
 
144 - Heinimann K (1998)
Heinimann K, Mullhaupt B, Weber W. Phenotypic differences in familial adenomatous polyposis based on APC germline mutation status. Gut 1998 43:675-9.
 
145 - Heiskanen I (1999)
Heiskanen I, Kellokumpu I, Järvinen H. Management of duodenal adenomas in 98 patients with familial adenomatous polyposis. Endoscopy 1999;31:412-16.
 
146 - Hendriks YM (2004)
Hendriks YM, Wagner A, Morreau H, Menko F, Stormorken A, Quehenberger F et al. Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance. Gastroenterology 2004;27:17-25.
 
147 - Hendriks YMC (2006)
Hendriks YMC, Jagmohan-Changur S, Van der Klift HM, Moreau H, Van Puijenbroek M, Tops C et al. Heterozygous mutations in PMS2 cause hereditary nonpolyposis colorectal carcinoma (Lynch syndrome). Gastroenterology 2006;130:312-22.
 
148 - Hernegger GS (2002)
Hernegger GS, Moore HG, Guillem JG. Attenuated familial adenomatous polyposis. An evolving and poorly understood entity. Dis Colon Rectum 2002;45:27-36.
 
149 - Higuchi (2003)
Higuchi T, Iwama T, Yoshinaga K, Toyooka M, Taketo MM, Sugihara K. A randomized, double-blind, placebo-controlled trial of the effects of rofecoxib, a selective cyclooxygenase-2 inhibitor, on rectal polyps in familial adenomatous polyposis patients. Clin Cancer Res 2003;9:4756-60.
 
150 - Hirota WK (2006)
Hirota WK, Zuckerman MJ, Adler DG. ASGE Guideline: The role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc 2006;63:570-80.
 
151 - Holt WS Jr (1991)
Holt WS Jr. Factors affecting compliance with screening sigmoidoscopy. J Fam Pract. 1991;32:585-9.
 
152 - Holloway S (2005)
Holloway S, Porteous M, Cetnarskyj R, Rush R, Appleton S, Gorman D et al. Referrals of patients to colorectal cancer genetics services in south-east Scotland. Fam Cancer 2005;4:151-61.
 
153 - Hookey LC (2004)
Hookey LC, Depew WT, Vanner SJ. A prospective randomized trial comparing low-dose oral sodium phosphate plus stimulant laxatives with large volume polyethylene glycol solution for colon cleansing. Am J Gastroenterol 2004;99:2217-22.
 
154 - Houlston RS (1990)
Houlston RS, Murday V, Harocopos C, Williams CB, Slack J. Screening and genetic counselling for relatives of patients with colorectal cancer in a family cancer clinic. BMJ 1990;301:366-8.
 
155 - Hsu CW (1998)
Hsu CW, Imperiale TF. Meta-analysis and cost comparison of polyethylene glycol lavage versus sodium phosphate for colonoscopy preparation. Gastrointest Endosc 1998;48:276-82.
 
156 - Stracham T (2004)
Stracham T, Read AP, Human Molecular Genetics. red. Garland Publishing, London, New York, 2004
 
157 - Huppertz-Hauss G (2005)
Huppertz-Hauss G, Bretthauer M, Sauar J, Paulsen J, Kjellevold O, Majak B, et al. Polyethylene glycol versus sodium phosphate in bowel cleansing for colonoscopy: a randomized trial. Endoscopy 2005;37:537-41.
 
158 - Hwang KL (2005)
Hwang KL, Chen WT, Hsiao KH, Chen HC, Huang TM, Chiu CM, et al. Prospective randomized comparison of oral sodium phosphate and polyethylene glycol lavage for colonoscopy preparation. World J Gastroenterol 2005;11:7486-93.
 
159 - Iida M (1988)
Iida M, Yao T, Itoh H, Watanabe H, Matsui T, Iwashita A et al. Natural history of gastric adenomas in patients with familial adenomatous coli/ Gardner´s syndrome. Cancer 1988;61:605-11.
 
160 - Jablonska M (1995)
Jablonska M, Reznikova L, Kotrlik J, Svitavsky M, Mikova M, Tabach J. Clinical implications of recognition of the hereditary non-polyposis colon cancer syndrome (HNPCC) for the early detection of colorectal cancer. Sb Lek 1995;96:275-82.
 
161 - James AS (2002)
James AS, Campbell MK, Hudson MA. Perceived barriers and benefits to colon cancer screening among African Americans in North Carolina: how does perception relate to screening behavior? Cancer Epidemiol Biomarkers Prev 2002;11:529-34.
 
162 - Janinis J (2003)
Janinis J, Patriki M, Vini L, Aravantinos G, Whelan JS. The pharmacological treatment of aggressive fibromatosis: a systematic review. Ann Oncol 2003;14:181-90.
 
163 - Järvinen HJ (1995)
Järvinen HJ, Mecklin JP, Sistonen P. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 1995;108:1405-11.
 
164 - Järvinen HJ (2000)
Järvinen HJ, Aarnio M, Mustonen H, Aktan-Collan K, Aaltonen LA, Peltomäki P et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 2000:118:829-34.
 
165 - Jass JR et al (1992)
Jass JR et al. Screening for hereditary non-polyposis colorectal cancer in New Zealand. Eur J Gastroenterol Hepatol 1992;4:523-27.
 
166 - Johns LE (2001)
Johns LE, Houlston RS. A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol 2001;96:2992-3003.
 
167 - de Jong AE (2004)
de Jong AE, Morreau H, Van Puijenbroek M, Eilers PH, Wijnen J, Nagengast FM et al. The role of mismatch repair gene defects in the development of adenomas in patients with HNPCC. Gastroenterology 2004;126:42-8.
 
168 - de Jong AE (2006)
de Jong AE, Hendriks YMC, Kleibeuker JH, De Boer SY, Cats A, Griffioen G et al. Decrease in mortality in Lynch syndrome families because of surveillance. Gastroenterology 2006;130:665-71.
 
169 - de Jong AE (2006)
de Jong AE, Vasen HF. The frequency of a positive family history for colorectal cancer: a population-based study in the Netherlands. Neth J Med 2006;64:367-70.
 
170 - Julian-Reynier C (2003)
Julian-Reynier C, Welkenhuysen M, Hagoel L, Decruyenaere M, Hopwood P, CRISCOM Working Group. Risk communication strategies: state of the art and effectiveness in the context of cancer genetic services. Eur J Hum Genet. 2003;11:725-36.
 
171 - Jüni P (2004)
Jüni P, Nartey L, Reichenbach S, Sterchi R, Dieppe PA, Egger M. Risk of cardiovascular events and rofecoxib: cumulative meta-analysis. Lancet 2004;364:2021-9.
 
172 - Kartheuser A (2006)
Kartheuser A, Stangherlin P, Brandt D, Remue C, Sempour C. Restorative proctocolectomy and ileal pouch-anal anastomosis for familial adenomatous polyposis revisited. Fam Cancer 2006;5:241-60.
 
173 - Kastrinos F (2007)
Kastrinos F. Attutudes towards PGD in patients with FAP, Am J Gastroenterol 2007;102:1284-90.
 
174 - Kauff ND (2002)
Kauff ND, Satagopan JM, Robson ME, Scheuer L, Hensley M, Hudis CA et al. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 2002;346:1609-15.
 
175 - Keller M (2004)
Keller M, Sommerfeldt S, Fischer C, Knigth L, Riesbeck M, Lowe B et al. Recognition of distress and psychiatric morbidity in cancer patients: a multi-method approach. Ann Oncol 2004;15:1243-9.
 
176 - Kerber RA (1997)
Kerber RA, Slattery ML. Comparison of self reported and database linked family history of cancer data in a case-control study. Am J Epidem 1997;146:244-8.
 
177 - Kerber RA (1998)
Kerber RA, Slattery ML, Potter JD, Caan BJ, Edwards SL. Risk of colon cancer associated with a family history of cancer or colorectal polyps: the diet, activity, and reproduction in colon cancer study. Int J Cancer 1998;78:157-60.
 
178 - Kerber RA (2005)
Kerber RA, Neklason DW, Samowitz WS, Burt RW. Frequency of familial colon cancer and hereditary nonpolyposis colorectal cancer (Lynch syndrome) in a large population database. Fam Cancer 2005;4: 239-44.
 
179 - Kets CM (2006)
Kets CM, van Krieken JH, Hebeda KM, Wezenberg SJ, Goossens M, Brunner HG et al. Very low prevalence of germline MSH6 mutations in hereditary non-polyposis colorectal cancer suspected patients with colorectal cancer without microsatellite instability. Br J Cancer 2006;95:1678-82.
 
180 - Kiesslich R (2001)
Kiesslich R, von Bergh M, Hahn M, Hermann G, Jung M. Chromoendoscopy with indigocarmine improves the detection of adenomatous and nonadenomatous lesions in the colon. Endoscopy 2001;33:1001-6.
 
181 - Kievit W (2004)
Kievit W, de Bruin JH, Adang EM, Ligtenberg MJ, Nagengast FM, van Krieken JH et al. Current clinical selection strategies for identification of hereditary non-polyposis colorectal cancer families are inadequate: a meta-analysis. Clin Genet. 2004;65:308-16.
 
182 - Kievit W (2005)
Kievit W, de Bruin JH, Adang EM, Severens JL, Kleibeuker JH, Sijmons RH et al. Cost effectiveness of a new strategy to identify HNPCC patients. Gut 2005;54:97-102.
 
183 - Kiesslich R (2001)
Kiesslich R, von Bergh M, Hahn M, Hermann G, Jung M. Chromoendoscopy with indigocarmine improves the detection of adenomatous and nonadenomatous lesions in the colon. Endoscopy 2001;33:1001-6.
 
184 - Kinney AY (2000)
Kinney AY, Choi YA, De Vellis B, Kobetz E, Millikan RC, Sandler RS. Interest in genetic testing among first-degree relatives of colorectal cancer patients. Am J Prev Med 2000;18:249-52.
 
185 - Kinzler KW (1991)
Kinzler KW, Nilbert MC, Lu LK, Vogelstein B, Bryan TM, Levy DB et al. Identification of FAP locus genes from chromosome 5q21. Science 1991;253:661-5.
 
186 - Kmietowicz Z (2004)
Kmietowicz Z. UK clinic allowed to screen embryos for rare bowel cancer. BMJ 2004; 329;1061.
 
187 - Knoppers BM (2004)
Knoppers BM, Isasi RM. Regulatory approaches to reproductive genetic testing. Hum Reprod 2004;19;2695-701.
 
188 - Koehly LM (2003)
Koehly LM, Peterson WK, Watts BG, Kempf KK, Vernon SW, Gritz ER. A social network analysis of communication about hereditaray nonpolyposis colorectal cancer genetic testing and family functioning. Cancer Epidemiol Biomarkers Prev 2003;12;304-13.
 
189 - Koinuma K (2004)
Koinuma K, Shitoh K, Miyakura Y, Furukawa T, Yamashita Y, Ota J et al. Mutations of BRAF are associated with extensive hMLH1 promoter methylation in sporadic colorectal carcinomas. Int J Cancer. 2004;108:237-42.
 
190 - Kune GA (1989)
Kune GA, Kune S, Watson LF. The role of heredity in the etiology of large bowel cancer: data from the Melbourne Colorectal Cancer Study. World J Surg 1989;13:124-9.
 
191 - Follow-up na poliepectomie (2002)
Kwaliteitsinstituut voor de gezondheidszorg CBO. Follow-up na poliepectomie. Utrecht: van Zuiden Communications; 2002.
 
192 - Vroege opsporing van dikkedarmkanker (2004)
KWF kankerbestrijding. Vroege opsporing van dikkedarmkanker. Minder sterfte door bevolkingsonderzoek. Signaleringscommissie Kanker van KWF Kankerbestrijding. 2004.
 
193 - Labayle D (1991)
Labayle D, Fischer D, Vielh P, Drouhin F, Pariente A, Bories C et al. Sulindac causes regression of rectal polyps in familial adenomatous polyposis, Gastroenterology 1991;101:635-9.
 
194 - Laframboise S (2002)
Laframboise S, Nedelcu R, Murphy J, Cole DE, Rosen B. Use of CA-125 and ultrasound in high-risk women. Int J Gynecol Cancer 2002;12:86-91.
 
195 - Lanspa SJ (1994)
Lanspa SJ, Jenkins JX, Cavalieri RJ, Smyrk TC, Watson P, Lynch J et al. Surveillance in Lynch syndrome: how aggressive? Am J Gastroenterology 1994;89:1978-80.
 
196 - Latchford A (2006)
Latchford A, Gallagher M, Newton D et al. Therapeutic endoscopy for duodenal adenomatosis in familial adenomatous polyposis. Abstract DDW 2006.
 
197 - Leite JS (2005)
Leite JS, Isidro G, Martins M, Regateiro F, Albuquerque O, Amaro P et al. Is prophylactic colectomy indicated in patients with MYH-associated polyposis? Colorect Dis 2005;7:327-31.
 
198 - Lessick M (1998)
Lessick M, Faux S. Implications of genetic testing of children and adolescents. Holist Nurs Pract 1998;12:38-46.
 
199 - Lewis SF (1996)
Lewis SF, Jensen NM. Screening sigmoidoscopy. Factors associated with utilization. J Gen Intern Med 1996:11:542-4.
 
200 - Lim CL (1986)
Lim CL, Walker MJ, Mehta RR, Das Gupta TK. Estrogen and antiestrogen binding sites in desmoid tumors. Eur J Cancer Clin Oncol 1986;22: 583-7.
 
201 - Lindor NM (2005)
Lindor NM, Rabe K, Petersen GM, Haile R, Casey G, Baron J et al. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA 2005;293:1979-85.
 
202 - Lindor NM (2006)
Lindor NM, Petersen GM, Hadley DW, Kinney AY, Miesfeldt S, Lu KH et al. Recommendations for the care of individuals with an inhereted predisposition to Lynch syndrome: a systematic review. JAMA 2006 296:1507-17.
 
203 - Lipton L (2004)
Lipton L, Tomlinson I. The multiple colorectal adenoma phenotype and MYH, a base excision repair gene. Clin Gastroenterol Hepatol 2004;2:633-8.
 
204 - Lynch HT (1993)
Lynch HT, Smyrk TC, Lanspa SJ, Jenkins JX, Cavalieri J, Lynch JF. Cancer control problems in the lynch syndromes. Dis Colon Rectum 1993;36:254-60.
 
205 - Lynch HT (1996)
Lynch HT, Fitzgibbons R Jr. Surgery, desmoid tumors, and familial adenomatous polyposis: case report and literature review. Am J Gastroenterology 1996;91:2598-601.
 
206 - Lynch HT (1996)
Lynch HT, Lemon S, Smyrk T, Franklin B, Karr B, Lynch J et al. Genetic counseling in hereditary nonpolyposis colorectal cancer: an extended family with MSH2 mutation. Am J Gastroenterol 1996;91:2489-93.
 
207 - Lynch HT (2003)
Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med. 2003; 348:919-32.
 
208 - Lynch HT (2004)
Lynch HT, Riley BD, Weissman SM, Coronel SM, Kinarsky Y, Lynch JF et al. Hereditary nonpolyposis colorectal carcinoma (HNPCC) and HNPCC-like families: Problems in diagnosis, surveillance, and management. Cancer 2004;100:53-64.
 
209 - Maartense S (2004)
Maartense S, Dunker M, Slors JF, Cuesta MA, Gouma DJ, van Deventer SJ et al. Hand-assisted laparoscopic versus open restorative proctocolectomy with ileal pouch-anal anastomosis. A randomised trial. Ann Surg 2004;240:984-92.
 
210 - Madalinska JB (2005)
Madalinska JB, Hollenstein J, Bleiker E, van Beurden M, Valdimarsdottir HB, Massuger LF et al. Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer. J Clin Oncol 2005;23:6890-8.
 
211 - Madalinska JB (2006)
Madalinska JB, van Beurden M, Bleiker EM, Valdimarsdottir HB, Hollenstein J, Massuger LF et al. The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy. J Clin Oncol 2006;24:3576-82.
 
212 - Mathus-Vliegen EM (2006)
Mathus-Vliegen EM, Kemble UM. A prospective randomized blinded comparison of sodium phosphate and polyethylene glycol-electrolyte solution for safe bowel cleansing. Aliment Pharmacol Ther 2006;23:543-52.
 
213 - Matloff ET (2000)
Matloff ET, Shappell H, Brierley K, Bernhardt BA, McKinnon W, Peshkin BN. What would you do? Specialists' perspectives on cancer genetic testing, prophylactic surgery, and insurance discrimination. J Clin Oncol 2000;18:2484-92.
 
214 - McConkie-Rosell A (2004)
McConkie-Rosell A, Spiridigliozzi GA. 'Family matters': a conceptual framework for genetic testing in children. J Genet Couns 2004;13:9-29.
 
215 - McGivern A (2004)
McGivern A, Wynter CV, Whitehall VL, Kambara T, Spring KJ, Walsh MD et al. Promoter hypermethylation frequency and BRAF mutations distinguish hereditary non-polyposis colon cancer from sporadic MSI-H colon cancer. Fam Cancer 2004;3:101-7.
 
216 - Mecklin JP (1993)
Mecklin JP, Järvinen H. Treatment and follow-up strategies in hereditary nonpolyposis colorectal carcinoma. Dis Colon Rectum 1993;36:927-9.
 
217 - Meeuwissen PA (2005)
Meeuwissen PA, Seynaeve C, Brekelmans CT, Meijers-Heijboer HJ. Klijn JG, Burger CW. Outcome of surveillance and prophylactic salpingo-oophorectomy in asymptomatic women at high risk for ovarian cancer. Gynecol Oncol 2005;97:476-82.
 
218 - Meiser B (2005)
Meiser B. Psychological impact of genetic testing for cancer susceptibility: an update of the literature. Psycho-oncology 2005;14:1060-74.
 
219 - Menko FH (1999)
Menko FH, Griffioen G, Wijnen JT, Tops CM, Fodde R, Vasen HF. Genetica van darmkanker. I. Non-polyposis en polyposisvormen van erfelijke darmkanker. Ned Tijdschr Geneeskd. 1999;143:1201-6.
 
220 - Menko FH (2007)
Menko FH, Ligtenberg MJ, Brouwer T, Hahn D, Ausems M. DNA diagnostiek naar erfelijke aanleg voor tumoren. Een overzicht met aanbevelingen voor de praktijk. Ned Tijdschr Geneeskd 2007; 151: 295-8.
 
221 - Meyer TJ (1995)
Meyer TJ, Mark MM. Effects of psychosocial interventions with adult cancer patients: a meta-analysis of randomized experiments. Health Psychol 1995;14:101-8.
 
222 - Meyskens FL Jr (2002)
Meyskens FL Jr. Chemoprevention of FAP with sulindac. Curr Oncol Rep. 2002;4:463.
 
223 - Michie S (2001)
Michie S, Bobrow M, Marteau TM. Predictive genetic testing in children and adults: a study of emotional impact. J Med Genet 2001;38:519-26.
 
224 - Middleton SB (2003)
Middleton SB, Clark SK, Matravers P, Katz D, Reznek R, Phillips RK. Stepwise progression of familial adenomatous polyposis-associated desmoid precursor lesions demonstrated by a novel CT scoring system. Dis Colon Rectum 2003;46:481-5.
 
225 - Morrison PJ (2005)
Morrison PJ. Insurance, unfair discrimination, and genetic testing. Lancet 2005; 366:877-80.
 
226 - Moutou C (2006)
Moutou C, Gardes N, Nicod JC, Viville S. Strategies and outcomes of PGD of familial adenomatous polyposis. Mol Hum Reprod 2006;13:95-101.
 
227 - Mueller-Koch Y (2005)
Mueller-Koch Y, Vogelsang H, Kopp R, Lohse P, Keler G, Aust D et al. Hereditary non-polyposis colorectal cancer: clinical and molecular evidence for a new entity of hereditary colorectal cancer. Gut 2005; 54, 1733-40.
 
228 - Müller A (2004)
Müller A, Giuffre G, Edmonston TB, Mathiak M, Roggendorf B, Heinmöller E, Brodegger T et al. Challenges and pitfalls in HNPCC screening by microsatellite analysis and immunohistochemistry. J Mol Diagn 2004;6:308-15.
 
229 - Müller W (2001)
Müller W, Burgart LJ, Krause-Paulus R, Thibodeau SN, Almeida M, Edmonston TB et al. The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC)-results of an international collaborative study. Fam Cancer 2001;1:87-92.
 
230 - Murakami Y (2004)
Murakami Y, Okamura H, Sugano K, Yoshida T, Kazuma K, Akechi T et al. Psychologic distress after disclosure of genetic test results regarding hereditary nonpolyposis colorectal carcinoma. Cancer 2004;101:395-403.
 
231 - Myrhoj T (1997)

Myrhoj T, Bisgaard ML, Bernstein I, Svendsen LB, Sondergaard JO, Bülow S. Hereditary non-polyposis colorectal cancer: clinical features and survival. Results from the Danish HNPCC register. Scand J Gastroenterol 1997;32:572-6.

 
232 - Nagengast FM (2001)
Nagengast FM, Kaandorp CJE. Herziene CBO-richtlijn 'Follow-up na poliepectomie'. Ned Tijdschr Geneeskd. 2001;145:2022-5.
 
233 - NCCZ (1995)
NCCZ. Advies psychosociale zorg voor chronisch zieken. Zoetermeer: Nationale Commissie Chronisch Zieken, 1995.
 
234 - Nederlandse Kankerregistratie (2013)
Nederlandse Kankerregistratie: www.iknl.nl.
 
235 - Neoptolemos JP (1997)
Neoptolemos JP, Russell RC, Bramhall S, Theis B. Low mortality following resection for pancreatic and periampullary tumours in 1026 patients: UK survey of specialist pancreatic units. UK Pancreatic Cancer Group. Br J Surg 1997;84:1370-6.
 
236 - Nielsen M (2005)
Nielsen M, Franken PF, Reinards THC, Weiss MM, Wagner A, van der Klift H et al. Multiplicity in polyp count and extracolonic manifestations in 40 Dutch patients with MYH associated polyposis coli (MAP). J Med Genet 2005;42:e54.
 
237 - Nielsen M (2006)
Nielsen M, Poley JW, Verhoef S, van Puijenbroek M, Weiss MM, Burger GT et al. Duodenal carcinoma in MUTYH-associated polyposis. J Clin Pathol. 2006;59:1212-5.
 
238 - Niessen RC (2006)
Niessen RC, Berends MJ, Wu Y, Sijmons RH, Hollema H, Ligtenberg MJ et al. Identification of mismatch repair gene mutations in young colorectal cancer patients and patients with multiple HNPCC-associated tumours. Gut 2006;55:1781-8.
 
239 - Niv Y (1994)
Niv Y, Fraser GM. Adenocarcinoma in the rectal remnant in familial polyposis coli is not prevented by sulindac therapy. Gastroenterology 1994;107:854-7.
 
240 - Norton ID (2001)
Norton ID, Geller A, Petersen BT, Sorbi D, Gostout CJ. Endoscopic surveillance and ablative therapy for periampullary adenomas. Am J Gastroenterol 2001;96:101-106.
 
241 - Norum J (2000)
Norum J, Tranebjaerg L. Health, life and disability insurance and hereditary risk for breast or colorectal cancer. Acta Oncol 2000;39:189-93.
 
242 - Nugent KP (1992)
Nugent KP, Phillips RK. Rectal cancer risk in older patients with familial adenomatous polyposis and an ileorectal anastomosis: A cause for concern. Br J Surg 1992;79:1204-6.
 
243 - Nugent KP (1993)
Nugent KP, Farmer KC, Spigelman AD, Williams CB, Phillips RK. Randomized controlled trial of the effect on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis. Br J Surg 1993;80:1618-9.
 
244 - Oei AL (2006)
Oei AL, Massuger LF, Bulten J, Ligtenberg MJ, Hoogerbrugge N, de Hullu JA. Surveillance of women at high risk for hereditary ovarian cancer is inefficient. Br J Cancer 2006;94:814-819.
 
245 - Offerhaus GJA (1992)
Offerhaus GJA, Giardiello FM, Krush AJ, Booker SV, Tersmette AC, Kelley NC et al. The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology 1992;102:1980-2.
 
246 - Offit K (2004)
Offit K, Groeger S, Turner S, Wadsworth EA, Weiser MA. The 'duty to warn' a patient's family members about hereditary disease risks. JAMA 2004;292:1469-73.
 
247 - Offit K (2006)
Offit K, Kohut K, Clagett B, Wadsworth EA, Lafaro KJ, Cummings S et al. Cancer genetic testing and assisted reproduction. J Clin Oncol 2006;24:4775-82.
 
248 - Offringa M (2003)
Offringa M, Assendelft WJJ, Scholten RJPM, red. Bohn Stafleu Van Loghum. Inleiding in Evidence-based Medicine. Klinisch handelen gebaseerd op bewijsmateriaal., Houten, 2003.
 
249 - Ogino S (2006)
Ogino S, Cantor M, Kawasaki T, Brahmandam M, Kirkner GJ, Weisenberger DJ et al. CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies. Gut 2006;55:1000-6.
 
250 - Olivier RI (2006)
Olivier RI, Lubsen-Brandsma MA, Verhoef S, van Beurden M. CA125 and transvaginal ultrasound monitoring in high-risk women cannot prevent the diagnosis of advanced ovarian cancer. Gynecol Oncol 2006;100:20-6.
 
251 - Olivier RI (2004)
Olivier RI, van Beurden M, Lubsen MA, Rookus MA, Mooij TM, van de Vijver MJ et al. Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up. Br J Cancer 2004;90:1492-7.
 
252 - Oosterwijk JC (2005)
Oosterwijk JC, Ausems MGEM. Trends binnen de klinische genetica. Gebruik van erfelijkheidsonderzoek in de patiëntenzorg neemt toe. Med Contact 2005;60:1880-3.
 
253 - van Oostrom I (2006)
van Oostrom I, Meijers-Heijboer H, Duivenvoorden HJ, Brocker-Vriends AH, van Asperen CJ, Sijmons RH et al. Experience of parental cancer in childhood is a risk factor for psychological distress during genetic cancer susceptibility testing. Ann Oncol 2006;17:1090-5.
 
254 - van Oostrom I (2007)
van Oostrom I, Meijers-Heijboer H, Duivenvoorden HJ, Brocker-Vriends AH, van Asperen CJ, Sijmons RH et al. Prognostic factors for hereditary cancer distress six months after BRCA1/2 or HNPCC genetic susceptibility testing. Eur J Cancer 2007;43:71-7.
 
255 - Petersen GM (1996)
Petersen GM. Genetic testing and counselling in familial adenomatous polyposis. Oncology 1996;10:89-94.
 
256 - Peterson SK (2003)
Peterson SK, Watts BG, Koehly LM, Vernon SW, Baile WF, Kohlmann WK et al. How families communicate about HNPCC genetic testing: findings from a qualitative study. Am J Med Genet 2003;119C:78-86.
 
257 - Phillips RK (2002)

Phillips RK, Wallace MH, Lynch PM, Hawk E, Gordon GB, Saunders BP et al. A randomized, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis. Gut 2002;50:857-60.

 
258 - Pieterse AH (2005)
Pieterse AH , Ausems MG, Van Dulmen AM, Beemer FA, Bensing JM. Initial cancer genetic counseling consultation: change in counselees' cognitions and anxiety, and association with addressing their needs and preferences. Am J Med Genet A. 2005;137:27-35.
 
259 - Pieterse AH (2005)
Pieterse AH, Van Dulmen AM, Ausems MG, Beemer FA, Bensing JM. Communication in cancer genetic counselling: does it reflect counselees' previsit needs and preferences? Br J Cancer 2005;92:1671-8.
 
260 - Pieterse AH (2005)
Pieterse AH, Ausems MG, Van Dulmen AM, Beemer FA, Bensing JM. Initial cancer genetic counseling consultation: change in counselees' cognitions and anxiety, and association with addressing their needs and preferences. Am J Med Genet 2005;A 137:27-35.
 
261 - Piñol V (2005)
Piñol V, Castells A, Andreu M, Castellvi-Bel S, Alenda C, Llor X et al. Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. JAMA 2005;293:1986-94.
 
262 - Plaschke J (2004)
Plaschke J, Engel C, Kruger S, Holinski-Feder E, Pagenstecher C, Mangold E et al. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium. J Clin Oncol 2004;22:4486-94.
 
263 - The Polyposis Registry (2006)
The Polyposis Registry. London, UK. Protocol for the management of patients with polyposis. A guide for medical staff, 2006.
 
264 - Ponz de Leon M (2004)
Ponz de Leon M, Benatti P, Di Gregorio C, Pedroni M, Losi L, Genuardi M et al. Genetic testing among high-risk individuals in families with hereditary nonpolyposis colorectal cancer. Br J Cancer 2004;90:882-7.
 
265 - Pool G (2004)
Pool G, Heuvel F, Ranchor AV, Sanderman R. Handboek Psychologische Interventies bij Chronisch-somatische Aandoeningen. Assen: Koninklijke van Gorcum, 2004.
 
266 - Poon R (2001)
Poon R, Smits R, Li C,Jagmohan-Changur S, Kong M, Cheon S et al. Cyclooxygenase-two (COX-2) modulates proliferation in aggressive fibromatosis (desmoid tumor). Oncogene 2001;20:451-60.
 
267 - Porteous M (2003)

Porteous M, Dunckley M, Appleton S, Catt S, Dunlop M, Campbell H et al. Is it acceptable to approach colorectal cancer patients at diagnosis to discuss genetic testing? A pilot study. Br J Cancer 2003;89:1400-2.

 
268 - Quehenberger F (2005)
Quehenberger F, Vasen HF, van Houwelingen HC. Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment. J Med Genet. 2005;42:491-6.
 
269 - Ramsey SD (2003)
Ramsey SD, Wilson S, Spencer A, Geidzinska A, Newcomb P. Attitudes towards genetic screening for predisposition to colon cancer among cancer patients, their relatives and members of the community. Results of focus group interviews. Comm. Genet. 2003;6:29-36.
 
270 - Rebbeck TR (2002)
Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, Van 't Veer L, Garber JE et al. Prevention and Observation of Surgical End Points Study Group. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 2002;346:1616-22.
 
271 - Remzi FH (2001)
Remzi FH, Church JM, Bast J, LAvery IC, Strong SA, Hull TL et al. Mucosectomy vs stapeled ileal pouch-anal anastomosis in patients with familial adenomatous polyposis functional outcome and neoplasia control. Dis Colon Rectum 2001;44:1590-6.
 
272 - Renkonen-Sinisalo L (2006)
Renkonen-Sinisalo L, Bützow R, Leminen A, Lehtovirta P, Mecklin JP, Järvinen HJ. Surveillance for endometrial cancer in hereditary nonpolyposis colorectal cancer syndrome. Int J Cancer 2006;120:821-4.
 
273 - Rex DK (2000)
Rex DK, Johnson DA, Lieberman DA, Burt RW, Sonnenberg A. Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology. Am J Gastroenterol. 2000;95:868-77.
 
274 - Rich EC (2004)
Rich EC, Burke W, Heaton CJ, Haga S, Pinsky L, Short MP et al. Reconsidering the family history in primary care. J.Gen.Intern.Med. 2004;19:273-80.
 
275 - Richard CS (1997)
Richard CS, Berk T, Bapat BV, Haber G, Cohen Z, Gallinger S. Sulindac for periampullary polyps in FAP patients. Int J Colorectal Dis 1997;12:14-8.
 
276 - Richardson JL (1995)
Richardson JL, Danley K, Mondrus GT, Deapen D, Mack T. Adherence to screening examinations for colorectal cancer after diagnosis in a first-degree relative. Prev Med 1995;24:166-70.
 
277 - Van Riet N (1997)
Van Riet N, Mineur MJ. Maatschappelijk werk in de (Intramurale) Gezondheidszorg. Assen: Van Gorcum, 1997.
 
278 - Risum S (2003)
Risum S, Bülow S. Doxorubicin treatment of an intra-abdominal desmoid tumour in a patient with familial adenomatous polyposis. Colorectal Dis 2003;5:585-6.
 
279 - Rijcken FEM (2002)
Rijcken FEM, Hollema H, Kleibeuker JH. Proximal adenomas in hereditary non-polyposis colorectal cancer are prone to rapid malignant transformation. Gut 2002;50:291-2.
 
280 - Rijcken FE (2003)
Rijcken FE, Mourits MJ, Kleibeuker JH, Hollema H, Van der Zee AG. Gynecologic screening in hereditary nonpolyposis colorectal cancer. Gynecol Oncol 2003;91:74-80.
 
281 - Rijcken FEM (2003)
Rijcken FEM, Van der Sluis T, Hollema H, Kleibeuker JH. Hyperplastic polyps in hereditary nonpolyposis colorectal cancer. Am J Gastroenterol 2003;98:2306-11.
 
282 - Robb KA (2004)
Robb KA, Miles A, Wardle J. Demographic and psychosocial factors associated with perceived risk for colorectal cancer. Cancer Epidemiol Biomarkers Prev 2004;13:366-72.
 
283 - Samowitz WS (2005)
Samowitz WS, Albertsen H, Herrick J, Levin TR, Sweeney C, Murtaugh MA et al. Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology. 2005;129:837-45.
 
284 - Sampson JR (2003)
Sampson JR, Dolwani S, Jones S, Eccles D, Ellis A, Evans DG et al. Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH. Lancet 2003;362:39-41.
 
285 - Saurin JC (2002)
Saurin JC, Ligneau B, Ponchon T, Lepretre J, Chavaillon A, Napoleon B et al. The influence of mutation site and age on the severity of duodenal polyposis in patients with familial adenomatous polyposis. Gastrointest Endosc 2002;55:342-7.
 
286 - Schellevis et al (2005)
Schellevis et al. Tweede Nationale Studie, NIVEL, Utrecht 2005.
 
287 - Scheuer L (2002)
Scheuer L, Kauff N, Robson M, Kelly B, Barakat R, Satagopan J et al. Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. J Clin Oncol 2002;20:1260-8.
 
288 - Schmeler KM (2006)
Schmeler KM, Lynch HT, Chen L-M, Munsell MF, Soliman PT, Clark MB et al. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynchsyndrome. N Engl J Med 2006;354:261-9.
 
289 - Scholefield JH (1998)
Scholefield JH, Johnson AG, Shorthouse AJ. Current surgical practice in screening for colorectal cancer based on family history criteria. Br J Surg. 1998;85:1543-6.
 
290 - Scott RJ (2001)
Scott RJ, Mc Phillips M, Meldrum CJ, Fitzgerald PE, Adams K, Spigelman AD et al. Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds. Am J Hum Genet 2001;68:118-27.
 
291 - Scott RH (2007)
Scott RH, Homfray T, Huxter NL. Familial T-cell non-Hodgkin lymphoma caused by biallelic MSH2 mutations. J Med Genet 2007;44:e83.
 
292 - Seinela L (2003)
Seinela L, Pehkonen E, Laasanen T, Ahvenainen J. Bowel preparation for colonoscopy in very old patients: a randomized prospective trial comparing oral sodium phosphate and polyethylene glycol electrolyte lavage solution. Scand J Gastroenterology 2003;38:216-20.
 
293 - Setti-Carraro P (1996)
Setti-Carraro P, Nicholls RJ. Choice of prophylactic surgery for the large bowel component of familial polyposis. Br J Surg 1996;83:885-92.
 
294 - Seiter K (1993)
Seiter K, Kemeny N. Successful treatment of a desmoid tumour with doxorubicin. Cancer 1993;71: 2242-4.
 
295 - Sermijn E (2004)
Sermijn E, Goelen G, Teugels E, Kaufman L, Bonduelle M, Neyns B et al. The impact of proband mediated information dissemination in families with a BRCA1/2 gene mutation. J Med Genet 2004;41:e23.
 
296 - Seow-Choen F (1996)
Seow-Choen F, Vijayan V, Keng V. Prospective randomized study of sulindac versus calcium and calciferol for upper gastrointestinal polyps in familial adenomatous polyposis. Br J Surg 1996;1763-6.
 
297 - Shia J (2005)
Shia J, Klimstra DS, Nafa K, Offit K, Guillem JG, Markowitz AJ et al. Value of Immunohistochemical detection of DNA mismatch repair proteins in predicting germline mutation in hereditary colorectal neoplasms. Am J Surg Pathol 2005;29:96-104.
 
298 - Sieber OM (2006)
Sieber OM, Segditsas S, Knudsen AL, Zhang J, Luz J, Rowan AJ et al. Disease severity and genetic pathways in attenuated familial adenomatous polyposis vary greatly but depend on the site of the germline mutation. Gut 2006 ;55:1440-8.
 
299 - Sieber OM (2003)
Sieber OM, Lipton L, Crabtree M, Heinimann K, Fidalgo P, Phillips RK et al. Multiple colorectal adenoma, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med 2003;348:791-9.
 
300 - Trends, prognoses en implicaties zorgvraag (2004)
Signalerings Commissie Kanker van KWF Kankerbestrijding. Trends, Prognoses en Implicaties Zorgvraag. Oktober 2004.
 
301 - Signalerings Commissie Kanker (2004)
Signalerings Commissie Kanker van KWF Kankerbestrijding. De rol van voeding bij het ontstaan van kanker. KWF Kankerbestrijding 2004.
 
302 - Simpson JL (2005)
Simpson JL, Carson SA, Cisneros P. Preimplantation genetic diagnosis (PGD) for heritable neoplasia. J Natl Cancer Inst Monogr 2005;34:87-90.
 
303 - Slors JF (1995)
Slors JF, Ponson AE, Taat CW, Bosma A. Risk of residual rectal mucosa after proctocolectomy and ileal pouch-anal reconstruction with the double stapling technique. Dis Colon Rectum 1995;38:207-10.
 
304 - Sollner W (2001)
Sollner W, DeVries A, Steixner E, Lukas P, Sprinzl G, Rumpold G et al. How successful are oncologists in identifying patient distress, perceived social support, and need for psychosocial counselling? Br J Cancer 2001;84:179-85.
 
305 - Solomon SD (2005)
Solomon SD, McMurray JJ, Pfeffer MA, Wittes J, Fowler R, Finn P et al. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med 2005 352;1071-80.
 
306 - Southey MC (2005)
Southey MC, Jenkins MA, Mead L, Whitty J, Trivett M, Tesoriero AA et al. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer. J Clin Oncol. 2005;23:6524-32.
 
307 - Spigelman AD (1989)
Spigelman AD, Williams CB, Talbot IC, Domizio P, Phillips RKS. Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet 1989;2:783-5.
 
308 - Stanley AJ (2000)
Stanley AJ, Gaff CL, Aittomaki AK, Fabre LC, Macrae FA, StJohn J. Value of predictive genetic testing in management of hereditary non-polyposis colorectal cancer (HNPCC). Med J Aust. 2000;172:313-6.
 
309 - Stermer T (2004)
Stermer T, Hogdson S, Kavalier F, Watts S. Jones R. Patients' and professionals opinions of services for people at an increased risk of colorectal cancer; an exploratory qualitatieve study. Fam Cancer 2004;3;49-53.
 
310 - Steinbach GD (2000)
Steinbach GD, Lynch PM, Phillips RKS, Wallace MH, Hawk E, Gordon GB et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 2000;342:1946-52.
 
311 - Stephenson BM (1993)
Stephenson BM, Murday VA, Finan PJ, Quirke P, Dixon MF, Bishop DT. Feasibility of family based screening for colorectal neoplasia: experience in one general surgical practice. Gut 1993;34:96-100.
 
312 - Stirling D (2005)
Stirling D, Evans DG, Pichert G, Shenton A, Kirk EN, Rimmer S et al. Screening for familial ovarian cancer: failure of current protocols to detect ovarian cancer at an early stage according to the international Federation of gynecology and obstetrics system. J Clin Oncol 2005;23:5588-96.
 
313 - St John DJ (1993)
St John DJ, McDermott FT, Hopper JL, Debney EA, Johnson WR, Hughes ES. Cancer risk in relatives of patients with common colorectal cancer. Ann Intern Med 1993;118:785-90.
 
314 - Stopfer JE (2000)
Stopfer JE. Genetic counseling and clinical cancer genetics services. Sem Surg Oncol 2000;18:347-57.
 
315 - Sturt NJ (2006)
Sturt NJ, Clark SK. Current ideas in desmoid tumours; Fam. Cancer 2006;5:275-85.
 
316 - Suthers GK (2006)
Suthers GK, Armstrong J, McCormack J, Trott D. Letting the family know: balancing ethics and effectiveness when notifying relatives about genetic testing for a familial disorder. J Med Genet 2006;43: 665-70.
 
317 - Tan JJ (2006)
Tan JJ, Tjandra JJ. Which is the optimal bowel preparation for colonoscopy - a meta-analysis. Colorectal Dis 2006;8:247-58.
 
318 - Tenesa A (2006)
Tenesa A, Campbell H, Barnetson R, Barnetson R, Porteous M, Dunlop M, Farrington SM. Association of MUTYH and colorectal cancer. Br J Cancer 2006;95:239-42.
 
319 - Thomson A (1996)
Thomson A, Naidoo P, Crotty B. Bowel preparation for colonoscopy: a randomized prospective trial comparing sodium phosphate and polyethylene glycol in a predominantly elderly population. J Gastroenterol Hepatol 1996;11:103-7.
 
320 - Tjandra JJ (2004)
Tjandra JJ, Tagkalidis P. Carbohydrate-electrolyte (E-Lyte) solution enhances bowel preparation with oral fleet phospho-soda. Dis Colon Rectum 2004;47:1181-6.
 
321 - Tourino R (2004)
Tourino R, Conde-Freire R, Cabezas-Agricola JM, Rodriguez-Aves T, Lopez-Valladares MJ, Otero-Cepeda JL et al. Value of the congenital hypertrophy of the retinal pigment epithelium in the diagnosis of familial adenomatous polyposis. Int Ophthalmol 2004;25:101-12.
 
322 - Ullah N (2002)
Ullah N, Yeh R, Ehrinpreis M. Fatal hyperphosphatemia from a phosphosoda bowel preparation. J Clin Gastroenterol 2002;34:457-8.
 
323 - Umar A (2004)
Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Ruschoff J et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004;96:261-8.
 
324 - Umar A (2004)
Umar A, Risinger JI, Hawk ET, Barrett JC. Testing guidelines for hereditary non-polyposis colorectal cancer. Nat Rev Cancer 2004;4:153-8.
 
325 - Vasen HF (1995)
Vasen HF, Taal BG, Nagengast FM, Griffioen G, Menko FH, Kleibeuker JH et al. Hereditary nonpolyposis colorectal cancer: results of long-term surveillance in 50 families. Eur J Cancer 1995;31A:1145-8.
 
326 - Vasen HF (1996)
Vasen HF, Wijnen JT, Menko FH, Kleibeuker JH. Taal BG, Griffioen G et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 1996;110:1020-7.
 
327 - Vasen HFA (1996)
Vasen HFA, van der Luijt RB, Slors JF, Buskens E, de Ruiter P, Baeten CG et al. Molecular genetic tests as a guide to surgical management of familial adenomatous polyposis. Lancet 1996;348:433-5.
 
328 - Vasen HFA (1999)
Vasen HFA, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology 1999;116:1453-6.
 
329 - Vasen HF (2001)
Vasen HF, Stormorken A, Menko FH, Nagengast FM, Kleibeuker JH, Griffioen G et al. MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families. J Clin Oncol 2001;19:4074-80.
 
330 - Vasen HF (2005)
Vasen HF, Boland CR. Progress in genetic testing, classification, and identification of Lynch syndrome. JAMA. 2005;293:2028-30.
 
331 - Vasen HF (2005)
Vasen HF, Tesfay E, Boonstra H, Mourits MJ, Rutgers E, Verheyen R et al. Early detection of breast and ovarian cancer in families with BRCA mutations. Eur J Cancer 2005;41:549-54.
 
332 - Venesio T (2004)
Venesio T, Molatore S, Cattaneo F, Arrigoni A, Risio M, Ranzani GN. High frequency of MYH gene mutations in a subset of patients with familial adenomatous polyposis. Gastroenterology 2004;126:1681-5.
 
333 - Vernon WS (1997)
Vernon SW, Gritz ER, Peterson SK, Amos CI, Perz CA, Baile WF et al. Correlates of psychologic distress in colorectal cancer patients undergoing genetic testing for hereditary colon cancer Health Psychol 1997;16:73-86.
 
334 - de Vos tot Nederveen Cappel (2002)
de Vos tot Nederveen Cappel WH, Nagengast FM, Griffioen G, Menko FH, Taal BG, Kleibeuker JH et al. Surveillance for Hereditary Nonpolyposis Colorectal Cancer. Dis Colon Rectum 2002;45:1588-94.
 
335 - De Vos tot Nederveen Cappel (2003)
De Vos tot Nederveen Cappel WH, Buskens E, Van-Duijvendijk P, Cats A, Menko FH, Griffioen G et al. Decision analysis in the surgical treatment of colorectal cancer due to a mismatch repair gene defect. Gut 2003;52:1752-5.
 
336 - Vrouenraets BC (2004)
Vrouenraets BC, van Duijvendijk P, Bemelman WA, Offerhaus GJ, Slors JF. Adenocarcinoma in the anal canal ileal pouch-anal anastomosis for familial adenomatous polyposis using a double-stapled technique: report of two cases. Dis Colon Rectum 2004;47:530-4.
 
337 - Wagner A (2002)
Wagner A, Tops C, Wijnen JT, Zwinderman K, van der Meer C, Kest M et al. Genetic testing in hereditary non-polyposis colorectal cancer families with a MSH2, MLH1, or MSH6 mutation. J Med Genet 2002;39:833-7.
 
338 - Wagner A (2005)
Wagner A, van Kessel I, Kriege MG, Tops CM, Wijnen JT, Vasen HF et al. Long term follow-up of HNPCC gene mutation carriers: compliance with screening and satisfaction with counseling and screening procedures. Fam Cancer 2005;4:295-300.
 
339 - Wang L (2004)
Wang L, Baudhuin LM, Boardman LA, Steenblock KJ, Petersen GM, Halling KC et al. MYH mutations in patients with attenuated and classic polyposis and with young-onset colorectal cancer without polyps. Gastroenterology 2004 Jul;127(1):9-16.
 
340 - Wallace MH (2006)
Wallace MH, Lynch PM. The current status of chemoprevention in FAP. Fam Cancer 2006;5:289-94.
 
341 - Watson EK (1999)
Watson EK, Shickle D, Qureshi N, Emery J, Austoker J. The 'new genetics' and primary care: GPs' views on their role and the ireducational needs. Fam Pract. 1999;16:420-5.
 
342 - Watson P (2001)
Watson P, Lynch HT. Cancer risk in mismatch repair gene mutation carriers. Fam Cancer 2001;1:57-60.
 
343 - Weiss A (1989)
Weiss A, Lackman R. Low-dose chemotherapy of desmoid tumours. Cancer 1989;64:1192-4.
 
344 - Weitzel JN (1999)
Weitzel JN. Genetic cancer risk assessment Putting it all together. Cancer 1999;86(11 Suppl):2483-92.
 
345 - Welkenhuysen M (2001)
Welkenhuysen M, Evers-Kieboom, G. d'Ydewalle G. The language of uncertainty in genetic risk communication: framing and verbal versus numerical information. Patient Educ. Couns. 2001;43:179-87.
 
346 - Wennstrom J (1974)

Wennstrom J, Pierce ER, McKusick VA. Hereditary benign and malignant lesions of the large bowel. Cancer 1974;34:850-7.

 
347 - WHO (2000)
World Health Organization Classification of Tumours. Pathology and Genetics. Tumours of the Digestive System, Hamilton, S.R. & Aaltonen, L.A., eds., IARC Press, Lyon, 2000.
 
348 - White WB (2007)
White WB, West CR, Borer JS, Gorelick PB, Lavange L, Pan SX, et al. Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trials. Am J Cardiol 2007;99:91-8.
 
349 - Wong N (2001)
Wong N, Lasko D, Rabelo R, Pinsky L, Gordon PH, Foulkes W. Genetic counseling and interpretation of genetic testing in familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer. Dis Colon Rectum 2001;44:271-9.
 
350 - Dowling DJ (2000)

Dowling DJ, St John DJ, Macrae FA, Hopper JL. Yield from colonoscopic screening in people with a strong family history of common colorectal cancer. J Gastroenterol Hepatol 2000;15:939-944.

 
351 - Hunt LM (1998)
Hunt LM, Rooney PS, Hardcastle JD, Armitage NC. Endoscopic screening of relatives of patients with colorectal cancer. Gut 1998; 42: 71-75
 
352 - Syrigos KN (2002)
Syrigos KN, Charalampopoulos A, Ho JL, Zbar A, Murday VA, Leicester RJ. Colonoscopy in asymptomatic individuals with a family history of colorectal cancer. Ann Surg Oncol 2002; 9:439-443.
 
353 - Buchanan AH (2005)
Buchanan AH, Skinner CS, Rawl SM, Moser BK, Champion VL, Scott LL et al. Patients' interest in discussing cancer risk and risk management with primary care physicians. Patient.Educ.Couns 2005;57(1):77-87.
 
354 - Bleiker EMA (2007)
Bleiker EMA, Menko FH, Kluijt I, Taal BG, Gerritsma MA, Wever LDV et al. Colorectal cancer in the family: psychosocial distress and social issues in the years following genetic counselling. Hereditary Cancer in Clinical Practice 2007;5(2):59-66.
 
355 - Overbeek LI (2008)

Overbeek LI, Ligtenberg MJ, Willems RW, et al. Interpretation of immunohistochemistry for mismatch repair proteins is only reliable in a specialized setting. Am J Surg Pathol. 2008 Aug;32(8):1246-51. PubMed PMID: 18677806.

 
356 - RIch TA 2014 (2014)

Rich TA, Liu M, Etzel CJ, Bannon SA, et al. Comparison of attitudes regarding preimplantation genetic diagnosis among patients with hereditary cancer syndromes. Fam Cancer. 2014 Jun;13(2):291-9. doi: 10.1007/s10689-013-9685-0.

 
357 - Sie AS 2014 (2014)

Sie AS, Mensenkamp AR, Adang EM, et al. Fourfold increased detection of Lynch syndrome by raising age limit for tumour genetic testing from 50 to 70 years is cost-effective. Ann Oncol. 2014 Oct;25(10):2001-7. doi: 10.1093/annonc/mdu361. Epub 2014 Jul 31.

 
358 - Menko FH 2013 (2013)

Menko FH, Aalfs CM, Henneman L, et al.; Dutch Society for Clinical Genetics. Informing family members of individuals with Lynch syndrome: a guideline for clinical geneticists. Fam Cancer. 2013 Jun;12(2):319-24. doi: 10.1007/s10689-013-9636-9. PMID: 23535968.

 
359 - Aktan-Collan K 2013 (2013)

Aktan-Collan K, Kääriäinen H, Järvinen H, et al. A Psychosocial consequences of predictive genetic testing for Lynch syndrome and associations to surveillance behaviour in a 7-year follow-up study. Fam Cancer. 2013 Dec;12(4):639-46. doi: 10.1007/s10689-013-9628-9.

 
360 - Bleiker EM 2013 (2013)

Bleiker EM, Esplen MJ, Meiser B, et al. 100 years Lynch syndrome: what have we learned about psychosocial issues? Fam Cancer. 2013 Jun;12(2):325-39. doi: 10.1007/s10689-013-9653-8.

 
361 - Buchanan 2013 (2013)

Buchanan D, Clendenning M, Haile RW, et al. Identification of novel variants in colorectal cancer families by high-throughput exome sequencing. Cancer Epidemiol Biomarkers Prev. 2013 Jul;22(7):1239-51. doi: 10.1158/1055-9965.EPI-12-1226. Epub 2013 May 1

 
362 - Cragun D (2014)

Cragun D, Radford C, Dolinsky J, et al. Panel-Based Testing for Inherited Colorectal Cancer: A descriptive study of clinical testing performed by a U.S. Laboratory. Clin Genet. 2014 Feb 9. doi: 10.1111/cge.12359. [Epub ahead of print]

 
363 - DeRycke MS 2013 (2013)

DeRycke MS, Gunawardena SR, Middha S, et al. Identification of novel variants in colorectal cancer families by high-throughput exome sequencing. Cancer Epidemiol Biomarkers Prev. 2013 Jul;22(7):1239-51. doi: 10.1158/1055-9965.EPI-12-1226. Epub 2013 May 1

 
364 - Kilpivaara O 2013 (2013)

Kilpivaara O, Aaltonen LA. Diagnostic cancer genome sequencing and the contribution of germline variants. Science. 2013 Mar 29;339(6127):1559-62. doi: 10.1126/science.1233899.

 
365 - Knopperts AP 2013 (2013)

Knopperts AP, Nielsen M, Niessen RC, et al. Contribution of bi-allelic germline MUTYH mutations to early-onset and familial colorectal cancer and to low number of adenomatous polyps: case-series and literature review. Fam Cancer. 2013 Mar;12(1):43-50.

 
366 - Ngeow J 2013 (2013)

Ngeow J, Heald B, Rybicki LA, et al. Prevalence of germline PTEN, BMPR1A, SMAD4, STK11, and ENG mutations in patients with moderate-load colorectal polyps.Gastroenterology. 2013 Jun;144(7):1402-9, 1409.e1-5. doi: 10.1053/j.gastro.2013.02.001. Epub 2013 Feb 8

 
367 - Neveling K 2013 (2013)

Neveling K, Feenstra I, Gilissen C, et al. A post-hoc comparison of the utility of sanger sequencing and exome sequencing for the diagnosis of heterogeneous diseases. Hum Mutat. 2013 Dec;34(12):1721-6.

 
368 - Palles C 2013 (2013)

Palles C, Cazier JB, Howarth KM, et al. Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas. Nat Genet. 2013 Feb;45(2):136-44. doi: 10.1038/ng.2503. Epub 2012 Dec 23.

 
369 - Smith CG 2013 (2013)

Smith CG, Naven M, Harris R, et al. Exome resequencing identifies potential tumor-suppressor genes that predispose to colorectal cancer. Hum Mutat. 2013 Jul;34(7):1026-34. doi: 10.1002/humu.22333. Epub 2013 May 20.

 
370 - Tanskanen T 2013 (2013)

Tanskanen T, Gylfe AE, Katainen R, et al. Exome sequencing in diagnostic evaluation of colorectal cancer predisposition in young patients.Scand J Gastroenterol. 2013 Jun;48(6):672-8. doi: 10.3109/00365521.2013.783102. Epub 2013 Apr 2.

 
371 - Valle L 2014 (2014)

Valle L, Hernández-Illán E, Bellido F, et al. New insights into POLE and POLD1 germline mutations in familial colorectal cancer and polyposis. Hum Mol Genet. 2014 Jul 1;23(13):3506-12.

 
372 - de Voer RM 2013 (2013)

de Voer RM, Geurts van Kessel A, Weren RD, et al. Germline mutations in the spindle assembly checkpoint genes BUB1 and BUB3 are risk factors for colorectal cancer. Gastroenterology. 2013 Sep;145(3):544-7. doi: 10.1053/j.gastro.2013.06.001. Epub 2013 Jun 5.

 
373 - Eijzenga W (2014)
Eijzenga W, Bleiker EMA, Hahn DEE, et al. Psychosocial Aspects of Hereditary Cancer (PAHC) questionnaire: development and testing of a screening questionnaire for use in clinical cancer genetics. Psychooncology. 2014 Aug;23(8):862-9.
 
374 - Eijzenga W (2014)
Eijzenga W, Aaronson NK, Hahn DEE, et al. The effect of routine assessment of specific psychosocial problems on personalized communication, counselors' awareness, and distress levels in cancer genetic counseling practice: A randomized controlled trial. Journal of Clinical Oncology, 2014, 32 (27): 2998-3004.
 
375 - Eijzenga W (2015)
Eijzenga W, Bleiker EM, Ausems MG, et al. Routine assessment of psychosocial problems after cancer genetic counseling: Results from a randomized controlled trial. Clinical Genetics 2015 May; 87 (5): 419-27.
 
376 - Bleiker EMA (2013)
Bleiker EMA, Esplen MJ, Meiser B, et al. 100 years Lynch Syndrome: What have we learned about psychosocial issues? Familial Cancer 2013, 12 (2): 325-339.
 
377 - Clancy T (2010)
Clancy T. A clinicalperspective on ethicalargumentsaroundprenatal diagnosis andpreimplantationgenetic diagnosis for later onsetinheritedcancerpredispositions. Fam Cancer. 2010 Mar;9(1):9-14. doi: 10.1007/s10689-009-9271-7. Epub 2009 Jul 31.
 
378 - Cobben JM (2002)
Cobben JM, Bröcker-Vriends AH, Leschot NJ. Prenatal diagnosis for hereditary predisposition to mammary and ovarian carcinoma--defining a position. Ned Tijdschr Geneeskd. 2002 Aug 3;146(31):1461-5.
 
379 - Fiorentino F (2006)
Fiorentino F, Biricik A, Nuccitelli A, De Palma R, Kahraman S, Iacobelli M, Trengia V, Caserta D, Bonu MA, Borini A, Baldi M.Strategiesandclinicaloutcome of 250 cycles of PreimplantationGenetic Diagnosis for single gene disorder.s Hum Reprod. 2006 Mar;21(3):670-84. Epub 2005 Nov 25.
 
380 - Fortuny D (2009)
Fortuny D, Balmaña J, Graña B, Torres A, Ramón y Cajal T, Darder E, Gadea N, Velasco A, López C, Sanz J, Alonso C, Brunet J.Opinion aboutreproductivedecision making amongindividualsundergoing BRCA1/2 genetictesting in a multicentre Spanish cohort.Hum Reprod. 2009 Apr;24(4):1000-6. doi: 10.1093/humrep/den471. Epub 2008 Dec 26.
 
381 - Hershberger PE (2010)
Hershberger PE, Pierce PF.Conceptualizingcouples' decision making in PGD: emergingcognitive, emotional, andmoraldimensions. PatientEducCouns. 2010 Oct;81(1):53-62. doi: 10.1016/j.pec.2009.11.017. Epub 2010 Jan 8
 
382 - Julian-Reynier C (2009)

Julian-Reynier C, Chabal F, Frebourg T, Lemery D, Noguès C, Puech F, Stoppa-LyonnetD.Professionalsassess the acceptability of preimplantationgenetic diagnosis andprenatal diagnosis for managing inheritedpredispositiontocancer. J Clin Oncol. 2009 Sep 20;27(27):4475-80

 
383 - Lavery SA (2002)
Lavery SA, Aurell R, Turner C, Castello C, Veiga A, Barri PN, Winston RM.Preimplantationgenetic diagnosis: patients' experiencesand attitudes.Hum Reprod. 2002 Sep;17(9):2464-7.
 
384 - Menko FH (2013)
Menko FH, Aalfs CM, Henneman L, et al.; Dutch Society for Clinical Genetics. Informing family members of individuals with Lynch syndrome: a guideline for clinical geneticists. Fam Cancer. 2013 Jun;12(2):319-24. doi: 10.1007/s10689-013-9636-9. PMID: 23535968
 
385 - Moutou C (2007)
Moutou C, Gardes N, Nicod JC, Viville S.Strategiesandoutcomes of PGD of familialadenomatous polyposis. Mol Hum Reprod. 2007 Feb;13(2):95-101. Epub 2006 Nov 17.
 
386 - Ormondroyd E (2012)
Ormondroyd E, Donnelly L, Moynihan C, Savona C, Bancroft E, Evans DG, Eeles R, Lavery S, Watson M.Attitudes toreproductivegenetictesting in womenwho had a positive BRCA test beforehavingchildren: a qualitative analysis.Eur J Hum Genet. 2012 Jan;20(1):4-10. doi: 10.1038/ejhg.2011.146. Epub 2011 Aug 3.
 
387 - Orthomel (2010)
Orthomel 2010
 
388 - Petersen GM (1996)
Petersen GM. Genetictestingandcounselling in familialadenomatous polyposis. Oncology 1996;10:89-94.
 
389 - Simpson JL1 (2005)
Simpson JL1, Carson SA, Cisneros P.Preimplantationgenetic diagnosis (PGD) forheritableneoplasia. J Natl Cancer InstMonogr. 2005;(34):87-90.
 
390 - Staton AD (2008)
Staton AD, Kurian AW, Cobb K, Mills MA, Ford JM. Cancer risk reductionandreproductive concerns in female BRCA1/2 mutation carriers. Fam Cancer. 2008;7(2):179-86. Epub 2007 Nov 17.
 
391 - Eijzenga W (2015)
Eijzenga W, Bleiker EM, Ausems MG, Sidharta GN, Kolk LE vd, Velthuizen ME, Hahn DE, Aaronson NK. Routine assessment of psychosocial problems after cancer genetic counseling: Results from a randomized controlled trial. Clinical Genetics 2015 May; 87 (5): 419-427.
 
392 - Eijzenga W (2014)
Eijzenga W, Aaronson NK, Hahn DEE, Sidharta G, Kolk L vd, Velthuizen M, Ausems, MGE, Bleiker EMA. The effect of routine assessment of specific psychosocial problems on personalized communication, counselors' awareness, and distress levels in cancer genetic counseling practice: A randomized controlled trial. Journal of Clinical Oncology, 2014, 32 (27): 2998-3004.
 
393 - Bleiker EMA (2013)
Bleiker EMA, Esplen MJ, Meiser B, Petersen HV, Patenaude AF. 100 years Lynch Syndrome: What have we learned about psychosocial issues? Familial Cancer 2013, 12 (2): 325-339.
 
394 - Menko FH (2013)
Menko FH, Aalfs CM, Henneman L, Stol Y, Wijdenes M, Otten E, Ploegmakers MM, Legemaate J, Smets EM, de Wert GM, Tibben A; Dutch Society for Clinical Genetics.Informing family members of individuals with Lynch syndrome: a guideline for clinical geneticists.Fam Cancer. 2013 Jun;12(2):319-24. doi: 0.1007/s10689-013-9636-9.PMID: 23535968
 
395 - Baglietto L 2010 (2010)

Baglietto L, et al. Risks of Lynch syndrome cancers for MSH6 mutation carriers. Journal of the National Cancer Institute, 2010. 102(3):193-201.

 
396 - Barrow E 2009 (2009)

Barrow E, et al. Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations. Clinical genetics, 2009. 75(2):141-9.

 
397 - Boilesen AE 2008 (2008)

Boilesen AE, Bisgaard ML, Bernstein I. Risk of gynecologic cancers in Danish hereditary non-polyposis colorectal cancer families. Acta obstetricia et gynecologica Scandinavica, 2008. 87(11): 1129-35.

 
398 - Bonadona V 2011 (2011)

Bonadona V, et al. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA: the journal of the American Medical Association, 2011. 305(22): 2304-10.

 
399 - Borras E 2010 (2010)

Borras E, et al. MLH1 founder mutations with moderate penetrance in Spanish Lynch syndrome families. Cancer Res, 2010. 70(19): 7379-91

 
400 - Capelle LG 2010 (2010)

Capelle LG, et al., Risk and epidemiological time trends of gastric cancer in Lynch syndrome carriers in the Netherlands. Gastroenterology, 2010. 138(2):487-92.

 
401 - Dowty JG 2013 (2013)

Dowty JG, et al. Cancer risks for MLH1 and MSH2 mutation carriers. Human mutation, 2013. 34(3):490-7.

 
402 - Kempers MJ 2011 (2011)

Kempers MJ, et al. Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study. The lancet oncology, 2011;12(1): 49-55.

 
403 - Mukherjee B 2011 (2011)

Mukherjee B, et al. High risk of colorectal and endometrial cancer in Ashkenazi families with the MSH2 A636P founder mutation. Gastroenterology, 2011. 140(7): 1919-26.

 
404 - Ramsoekh D 2009 (2009)

Ramsoekh D, et al. Cancer risk in MLH1, MSH2 and MSH6 mutation carriers; different risk profiles may influence clinical management. Hereditary cancer in clinical practice, 2009. 7(1):17.

 
405 - Senter L 2008 (2008)

Senter L, et al. The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. Gastroenterology, 2008. 135(2):419-28.

 
406 - Steinke V 2011 (2011)

Steinke V, et al. Colorectal, endometrial and metachronous colorectalendometrial cancer risks in Lynch syndrome. Familial Cancer, 2011. 10: S31-S32.

 
407 - Stoffel E (2009)

Stoffel E, et al. Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome. Gastroenterology, 2009. 137(5):1621-7.

 
408 - Talseth-Palmer BA 2010 (2010)

Talseth-Palmer BA, et al. MSH6 and PMS2 mutation positive Australian Lynch syndrome families: novel mutations, cancer risk and age of diagnosis of colorectal cancer. Hereditary cancer in clinical practice, 2010. 8(1):5.

 
409 - Therkildsen C, 2012 (2012)

Therkildsen C, et al. Cancer risks and immunohistochemical profiles linked to the Danish MLH1 Lynch syndrome founder mutation. Familial cancer, 2012. 11(4) 579-85.

 
410 - van der Post RS 2010 (2010)

van der Post RS, et al. Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers. Journal of medical genetics, 2010. 47(7): 464-70.

 
411 - Watson P 2008 (2008)

Watson P, et al. The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome. Int J Cancer, 2008. 123(2): 444-9.

 
412 - Wijnen JT 2011 (2011)

Wijnen JT, et al. Cancer risk in Lynch syndrome families diagnosed with a PMS2 mutation. Familial Cancer, 2011. 10: S7

 
413 - Stuckless S 2013 (2013)

Stuckless S, et al. Impact of gynecological screening in Lynch syndrome carriers with an MSH2 mutation. Clinical genetics, 2013. 83(4): 359-64.

 
414 - Evans DG 2009 (2009)

Evans DG, et al. Risk-reducing surgery for ovarian cancer: outcomes in 300 surgeries suggest a low peritoneal primary risk. European journal of human genetics : EJHG, 2009. 17(11): 1381-5.

 
415 - Overbeek LI (2008)
Overbeek LI, Ligtenberg MJ, Willems RW, et al. Interpretation of immunohistochemistry for mismatch repair proteins is only reliable in a specialized setting. Am J Surg Pathol. 2008 Aug;32(8):1246-51. PubMed PMID: 18677806.
 
416 - Aktan-Collan K (2013)
Aktan-Collan K, Kääriäinen H, Järvinen H, et al. A Psychosocial consequences of predictive genetic testing for Lynch syndrome and associations to surveillance behaviour in a 7-year follow-up study. Fam Cancer. 2013 Dec;12(4):639-46. doi: 10.1007/s10689-013-9628-9.
 
417 - Belsey J (2012)
Belsey J, Crosta C, Epstein O, et al. Meta-analysis: The relative efficacy of oral bowel preparations for colonoscopy 1985-2010. Aliment Pharmacol Ther 2012;35:222–37. doi:10.1111/j.1365-2036.2011.04927.x
 
418 - Belsey J (2007)
Belsey J, Epstein O, Heresbach D. Systematic review: Oral bowel preparation for colonoscopy. Aliment. Pharmacol. Ther. 2007;25:373–84. doi:10.1111/j.1365-2036.2006.03212.x
 
419 - Bleiker EM (2013)
Bleiker EM, Esplen MJ, Meiser B, et al. 100 years Lynch syndrome: what have we learned about psychosocial issues? Fam Cancer. 2013 Jun;12(2):325-39. doi: 10.1007/s10689-013-9653-8.
 
420 - Corporaal S (2010)
Corporaal S, Kleibeuker JH, Koornstra JJ. Low-volume PEG plus ascorbic acid versus high-volume PEG as bowel preparation for colonoscopy. Scand J Gastroenterol 2010;45:1380–6. doi:10.3109/00365521003734158
 
421 - Ell C (2008)
Ell C, Fischbach W, Bronisch HJ, et al. Randomized trial of low-volume PEG solution versus standard PEG + electrolytes for bowel cleansing before colonoscopy. Am J Gastroenterol 2008;103:883–93. doi:10.1111/j.1572-0241.2007.01708.x
 
422 - Eun CS (2011)
Eun CS, Han DS, Hyun YS, et al. The timing of bowel preparation is more important than the timing of colonoscopy in determining the quality of bowel cleansing. Dig Dis Sci 2011;56:539–44. doi:10.1007/s10620-010-1457-1
 
423 - Fass R (1993)
Fass R, Do S, Hixson L. Fatal hyperphosphatemia following Fleet Phospo-Soda in a patient with colonic ileus. Am J Gastroenterol 1993;88:929–32.
 
424 - Hassan C (2013)
Hassan C, Bretthauer M, Kaminski MF, et al. Bowel preparation for colonoscopy: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2013;45:142–50. doi:10.1055/s-0032-1326186
 
425 - Health Canada (2013)
Health Canada. Pico-Salax (sodium picosulfate/magnesium citrate) and convulsions. Can Advers React Newsl 2013;23:1–2.
 
426 - Hsu CW (1998)
Hsu CW, Imperiale TF. Meta-analysis and cost comparison of polyethylene glycol lavage versus sodium phosphate for colonoscopy preparation. Gastrointest Endosc 1998;48:276–82. doi:10.1016/S0016-5107(98)70191-9
 
427 - Hurst FP (2007)
Hurst FP, Bohen EM, Osgard EM, et al. Association of oral sodium phosphate purgative use with acute kidney injury. J Am Soc Nephrol 2007;18:3192–8. doi:10.1681/ASN.2007030349
 
428 - Jansen SV (2011)
Jansen SV, Goedhard JG, Winkens B, et al. Preparation before colonoscopy: a randomized controlled trial comparing different regimes. Eur J Gastroenterol Hepatol 2011;23:897–902. doi:10.1097/MEG.0b013e32834a3444
 
429 - Juluri R (2010)
Juluri R, Eckert G, Imperiale TF. Meta-analysis: Randomized controlled trials of 4-L polyethylene glycol and sodium phosphate solution as bowel preparation for colonoscopy. Aliment Pharmacol Ther 2010;32:171–81. doi:10.1111/j.1365-2036.2010.04326.x
 
430 - Kao D (2011)
Kao D, Lalor E, Sandha G, et al. A randomized controlled trial of four precolonoscopy bowel cleansing regimens. Can J Gastroenterol 2011;25:657–62.
 
431 - Katz PO (2013)
Katz PO, Rex DK, Epstein M, et al. A dual-action, low-volume bowel cleanser administered the day before colonoscopy: results from the SEE CLEAR II study. Am J Gastroenterol 2013;108:401–9. doi:10.1038/ajg.2012.441
 
432 - Kilgore TW (2011)
Kilgore TW, Abdinoor AA, Szary NM, et al. Bowel preparation with split-dose polyethylene glycol before colonoscopy: A meta-analysis of randomized controlled trials. Gastrointest Endosc 2011;73:1240–5. doi:10.1016/j.gie.2011.02.007
 
433 - Lawrance IC (2011)
Lawrance IC, Willert RP, Murray K. Bowel cleansing for colonoscopy: Prospective randomized assessment of efficacy and of induced mucosal abnormality with three preparation agents. Endoscopy. 2011;43:412–8. doi:10.1055/s-0030-1256193
 
434 - Marmo R (2010)
Marmo R, Rotondano G, Riccio G, et al. Effective bowel cleansing before colonoscopy: A randomized study of split-dosage versus non-split dosage regimens of high-volume versus low-volume polyethylene glycol solutions. Gastrointest Endosc 2010;72:313–20. doi:10.1016/j.gie.2010.02.048
 
435 - Mathus-Vliegen E (2013)
Mathus-Vliegen E, Pellisé M, Heresbach D, et al. Consensus guidelines for the use of bowel preparation prior to colonic diagnostic procedures: colonoscopy and small bowel video capsule endoscopy. Curr Med Res Opin 2013;29:931–45. doi:10.1185/03007995.2013.803055
 
436 - Mesher D (2014)
Mesher D, Dove-Edwin I, Sasieni P, et al. A pooled analysis of the outcome of prospective colonoscopic surveillance for familial colorectal cancer. Int J Cancer. 2014 Feb 15;134(4):939-47. doi: 10.1002/ijc.28397. Epub 2013 Aug 29.
 
437 - Nagengast FM (2002)
Nagengast FM, Kaandorp CJE, van Ballegooijen M, et al. Follow-up na Poliepectomie - Herziene Richtlijn. Utrecht: Kwaliteitsinstituut voor de Gezondheidszorg CBO; 2002
 
438 - Pontone S (2011)
Pontone S, Angelini R, Standoli M, et al. Low-volume plus ascorbic acid vs high-volume plus simethicone bowel preparation before colonoscopy. World J Gastroenterol 2011;17:4689–95. doi:10.3748/wjg.v17.i42.4689
 
439 - Rex DK (2013)
Rex DK, Katz PO, Bertiger G, et al. Split-dose administration of a dual-action, low-volume bowel cleanser for colonoscopy: The SEE CLEAR i study. Gastrointest Endosc 2013;78:132–41. doi:10.1016/j.gie.2013.02.024
 
440 - Seo EH (2012)
Seo EH, Kim TO, Park MJ, et al. Optimal preparation-to-colonoscopy interval in split-dose PEG bowel preparation determines satisfactory bowel preparation quality: An observational prospective study. Gastrointest Endosc 2012;75:583–90. doi:10.1016/j.gie.2011.09.029
 
441 - Tan JJY (2006)
Tan JJY, Tjandra JJ. Which is the optimal bowel preparation for colonoscopy - A meta-analysis. Color. Dis. 2006;8:247–58. doi:10.1111/j.1463-1318.2006.00970.x
 
442 - Ullah N (2002)
Ullah N, Yeh R, Ehrinpreis M. Fatal hyperphosphatemia from a phosphosoda bowel preparation. 2002. J Clin Gastroenterol. 2002 Apr;34(4):457-8.
 
443 - van der Meulen AE (2011)
van der Meulen-de Jong AE, Morreau H, Becx MC, et al. High detection rate of adenomas in familial colorectal cancer. Gut. 2011 Jan;60(1):73-6. doi: 10.1136/gut.2010.217091. Epub 2010 Sep 9.
 
444 - van Heijningen EM (2002)

van Heijningen EM, Lansdorp-Vogelaar I, van Hees F, et al. Richtlijn 'Surveillance na Poliepectomie'. Voorstel nieuwe surveillance richtlijn voor adenoompatiënten - ter update van de CBO-richtlijn 'Follow-up na poliepectomie' (2002). Rotterdam: Department of Public Health, Erasmus MC; 2012

 
445 - van Lier MG 2012 (2012)

van Lier MG, Leenen CH, Wagner A, et al.; LIMO Study Group. Yield of routine molecular analyses in colorectal cancer patients ≤70 years to detect underlying Lynch syndrome. J Pathol. 2012 Apr;226(5):764-74. doi: 10.1002/path.3963. Epub 2012 Jan 17. PubMed PMID: 22081473.

 
446 - Mensenkamp AR 2013 (2014)

Mensenkamp AR, Vogelaar IP, van Zelst-Stams WA, et al. Somatic mutations in MLH1 and MSH2 are a frequent cause of mismatch-repair deficiency in Lynch syndrome-like tumors. Gastroenterology. 2014 Mar;146(3):643-646.e8. doi: 10.1053/j.gastro.2013.12.002. Epub 2013 Dec 10. PubMed PMID: 24333619

 
447 - Geurts-Giele WR 2014 (2014)

Geurts-Giele WR, Leenen CH, Dubbink HJ, et al. Somatic aberrations of mismatch repair genes as a cause of microsatellite-unstable cancers. J Pathol. 2014 Dec;234(4):548-59. doi: 10.1002/path.4419. Epub 2014 Sep 30.

 
448 - Kakar S 2003 (2003)

Kakar S, Burgart LJ, Thibodeau SN, et al. Frequency of loss of hMLH1 expression in colorectal carcinoma increases with advancing age. Cancer. 2003 Mar 15;97(6):1421-7.#http://www.ncbi.nlm.nih.gov/pubmed/12627505

 
449 - Ligtenberg MJ 2008 (2009)

Ligtenberg MJ, Kuiper RP, Chan TL, et al. Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1. Nat Genet. 2009 Jan;41(1):112-7. doi: 10.1038/ng.283. Epub 2008 Dec 21. PubMed PMID: 19098912.

 
450 - Niessen RC 2009 (2009)

Niessen RC, Hofstra RM, Westers H, et al. Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome. Genes Chromosomes Cancer. 2009 Aug;48(8):737-44. doi: 10.1002/gcc.20678. PubMed PMID: 19455606.

 
451 - Kuiper RP 2011 (2011)

Kuiper RP, Vissers LE, Venkatachalam R, et al. Recurrence and variability of germline EPCAM

deletions in Lynch syndrome. Hum Mutat. 2011 Apr;32(4):407-14. doi: 10.1002/humu.21446. Epub 2011 Mar 1. PubMed PMID: 21309036.

 
452 - Kalady MF 2010 (2010)

Kalady MF, McGannon E, Vogel JD, et al. Risk of colorectal adenoma and carcinoma after colectomy for colorectal cancer in patients meeting Amsterdam criteria. Ann Surg. 2010;252(3):507-11.

 
453 - Parry S 2011 (2011)

Parry S, Win AK, Parry B, et al. Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery. Gut. 2011 Jul;60(7):950-7.

 
454 - Messick CA 2014 (2014)

Messick CA, Kravochuck S, Church JM, et al. Metachronous serrated neoplasia is uncommon after right colectomy in patients with methylator colon cancers with a high degree of microsatellite instability. Dis Colon Rectum. 2014 Jan;57(1):39-46.

 
455 - Haanstra JF 2012 (2012)

Haanstra JF, de Vos Tot Nederveen Cappel WH, Gopie JP, et al. Quality of life after surgery for colon cancer in patients with Lynch syndrome: partial versus subtotal colectomy. Dis Colon Rectum. 2012 Jun;55(6):653-9.

 
456 - Win AK 2013 (2013)

Win AK, Parry S, Parry B, et al. Risk of metachronous colon cancer following surgery for rectal cancer in mismatch repair gene mutation carriers. Ann Surg Oncol. 2013 Jun;20(6):1829-36. Epub 2013 Jan 29.

 
457 - Robays J 2014 (2014)

Robays J, Poppe B. Oncogenetische testen voor Lynch syndroom en familiale adenomateuze polypose - Samenvatting. Brussel: Federaal Kenniscentrum voor de Gezondheidszorg (KCE); 2014. Good Clinical Practice (GCP) KCE Reports 220As

 
458 - Hoogerbrugge N 2012 (2012)

Hoogerbrugge N, Hermens RP, Nagengast FM, et al. Erfelijke darmkanker opsporen door tumoronderzoek. Ned Tijdschr Geneeskd. 2012;156:A4982.

 
459 - Sie AS 2014 (2014)

Sie AS, Mensenkamp AR, Adang EM, Ligtenberg MJ, Hoogerbrugge N. Fourfold increased detection of Lynch syndrome by raising age limit for tumour genetic testing from 50 to 70 years is cost-effective. Ann Oncol. 2014 Oct;25(10):2001-7

 
460 - KCE 2014 (2014)

Federaal Kenniscentrum voor de Gezondheidszorg (KCE). Erfelijke vormen van kanker aan de dikke darm, hoe identificeren? 2014. Available from: https://kce.fgov.be/nl/press-release/erfelijke-vormen-van-kanker-aan-de-dikke-darmhoe-identificeren

 
461 - Debniak T 2000 (2000)

Debniak T, Kurzawski G, Gorski B, et al. Value of pedigree/clinical data, immunohistochemistry and microsatellite instability analyses in reducing the cost of determining hMLH1 and hMSH2 gene mutations in patients with colorectal cancer. Eur J Cancer. 2000;36(1):49-54.

 
462 - Ramsey SD 2001 (2001)

Ramsey SD, Clarke L, Etzioni R, et al. Cost-effectiveness of microsatellite instability screening as a method for detecting hereditary nonpolyposis colorectal cancer. Ann Intern Med. 2001;135(8 Pt 1):577-88.

 
463 - Reyes CM 2002 (2002)

Reyes CM, Allen BA, Terdiman JP, et al. Comparison of selection strategies for genetic testing of patients with hereditary nonpolyposis colorectal carcinoma: effectiveness and cost-effectiveness. Cancer. 2002;95(9):1848-56.

 
464 - Ramsey SD 2003 (2003)

Ramsey SD, Burke W, Clarke L. An economic viewpoint on alternative strategies for identifying persons with hereditary nonpolyposis colorectal cancer. Genet Med.2003;5(5):353-63

 
465 - Kievit W 2005 (2005)

Kievit W, de Bruin JHFM, Adang EMM, et al. Cost effectiveness of a new strategy to identify HNPCC patients. Gut. 2005;54(1):97-102.

 
466 - Pinol V 2005 (2005)

Pinol V, Castells A, Andreu M, Castellvi-Bel S, Alenda C, Llor X, et al. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. JAMA. 2005;293(16):1986-94.

 
467 - Engel C 2006 (2006)

Engel C, Forberg J, Holinski-Feder E, et al. Novel strategy for optimal sequential application of clinical criteria, immunohistochemistry and microsatellite analysis in the diagnosis of hereditary nonpolyposis colorectal cancer. Int J Cancer. 2006;118(1):115-22.

 
468 - Barrow E 2008 (2008)

Barrow E, McMahon R, Evans DG, et al. Cost analysis of biomarker testing for mismatch repair deficiency in node-positive colorectal cancer. Br J Surg. 2008;95(7):868-75

 
469 - Yan HL 2008 (2008)

Yan HL, Hao LQ, Jin HY, et al. Clinical features and mismatch repair genes analyses of Chinese suspected hereditary non-polypsis colorectal cancer: A cost-effective screening strategy proposal. Cancer Science. 2008;99(4):770-80

 
470 - Mvundura M 2010 (2010)

Mvundura M, Grosse SD, Hampel H, et al. The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer. Genet Med. 2010;12(2):93-104.

 
471 - Gudgeon JM 2011 (2011)

Gudgeon JM, Williams JL, Burt RW, et al. Lynch syndrome screening implementation: Business analysis by a healthcare system. American Journal of Managed Care. 2011;17(8):e288-e300

 
472 - Ladabaum U 2011 (2011)

Ladabaum U, Wang G, Terdiman J, et al. Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis. Annals of Internal Medicine. 2011;155(2):69-79.

 
473 - Brazowski E 2012 (2012)

Brazowski E, Rozen P, Pel S, et al. Can a gastrointestinal pathologist identify microsatellite instability in colorectal cancer with reproducibility and a high degree of specificity? Familial Cancer. 2012;11(2):249-57

 
474 - Wang G 2012 (2012)

Wang G, Kuppermann M, Kim B, et al. Influence of patient preferences on the cost-effectiveness of screening for Lynch syndrome. Am J Manag Care. 2012;18(5):e179-85.

 
475 - Pigatto F 2004 (2004)

Pigatto F, Bateman A, Bunyan D, et al. Economic and Practical Factors in Diagnosing HNPCC Using Clinical Criteria, Immunohistochemistry and Microsatellite Instability Analysis. Hered Cancer Clin Pract. 2004;2(4):175-84.

 
476 - Aaltonen LA, 1998 (1998)

Aaltonen LA, Salovaara R, Kristo P, et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med. 1998;338(21):1481-7

 
477 - Samowitz WS 2001 (2001)

Samowitz WS, Curtin K, Lin HH, et al. The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer. Gastroenterology. 2001;121(4):830-8.

 
478 - Palomaki GE 2009 (2009)

Palomaki GE, McClain MR, Melillo S, et al. EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome. Genet Med. 2009;11:1-22.

 
479 - Berg AO 2009 (2009)

Berg AO, Armstrong K, Botkin J, et al. Recommendations from the EGAPP Working Group: Genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genetics in Medicine. 2009;11(1):35-41

 
480 - Vasen HFA 2010 (2010)

Vasen HFA, Moslein G, Alonso A, et al. Recommendations to improve identification of hereditary and familial colorectal cancer in Europe. Fam Cancer. 2010;9(2):109-15.

 
481 - Boland CR 198 (1998)

Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998;58(22):5248-57.

 
482 - Aaltonen LA 1994 (1994)

Aaltonen LA, Sankila R, Mecklin JP, et al. A novel approach to estimate the proportion of hereditary nonpolyposis colorectal cancer of total colorectal cancer burden. Cancer Detect Prev. 1994;18(1):57-63.

 
483 - Myrhoj T 1997 (1997)

Myrhoj T, Bisgaard ML, Bernstein I, et al. Hereditary non-polyposis colorectal cancer: clinical features and survival. Results from the Danish HNPCC register. Scand J Gastroenterol. 1997;32(6):572-6.

 
484 - Gryfe R 2000 (2000)

Gryfe R, Kim H, Hsieh ET, et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med. 2000;342(2):69-77.

 
485 - Percesepe A 1997 (1997)

Percesepe A, Benatti P, Roncucci L, et al. Survival analysis in families affected by hereditary non-polyposis colorectal cancer. Int J Cancer. 1997;71(3):373-6.

 
486 - Jarvinen HJ 2000 (2000)

Jarvinen HJ, Aarnio M, Mustonen H, et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology. 2000;118(5):829-34.

 
487 - Stupart DA 2009 (2009)

Stupart DA, Goldberg PA, Algar U, et al. Surveillance colonoscopy improves survival in a cohort of subjects with a single mismatch repair gene mutation. Colorectal Dis. 2009;11(2):126-30.

 
488 - Lynch HT 1999 (1999)

Lynch HT, Watson P, Shaw TG, et al. Clinical impact of molecular genetic diagnosis, genetic counseling, and management of hereditary cancer. Part I: Studies of cancer in families. Cancer. 1999;86(11 Suppl):2449-56.

 
489 - Biesecker BB 1993 (1993)

Biesecker BB, Boehnke M, Calzone K, et al. Genetic counseling for families with inherited susceptibility to breast and ovarian cancer. JAMA. 1993;269(15):1970-4.

 
490 - Lerman C 1994 (1994)

Lerman C, Croyle R. Psychological issues in genetic testing for breast cancer susceptibility. Arch Intern Med. 1994;154(6):609-16.

 
491 - Freyer G 1999 (1999)

Freyer G, Dazord A, Schlumberger M, et al. Psychosocial impact of genetic testing in familial medullary-thyroid carcinoma: a multicentric pilot-evaluation. Ann Oncol. 1999;10(1):87-95.

 
492 - CVZ 2006 (2006)

College voor zorgverzekeringen (CVZ). Richtlijnen voor farmaco-economisch onderzoek, geactualiseerde versie. 2006.

 
493 - USCS 2009 (2005)

US Cancer Statistics Working Group. United States cancer statistics: 1999-2005 incidence and mortality web-based report. Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2009. Available from: www.cdc.gov/uscs

 
494 - Hampel H 2005 (2005)

Hampel H, Frankel WL, Martin E, et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med. 2005;352(18):1851-60.

 
495 - Palomaki GE 2009 (2009)

Palomaki GE, McClain MR, Melillo S, et al. EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome. Genet Med. 2009;11(1):42-65.

 
496 - Ruszkiewicz A 2002 (2002)

Ruszkiewicz A, Bennett G, Moore J, et al. Correlation of mismatch repair genes immunohistochemistry and microsatellite instability status in HNPCC-associated tumours. Pathology. 2002;34(6):541-7

 
497 - Wahlberg SS 2002 (2002)

Wahlberg SS, Schmeits J, Thomas G, et al. Evaluation of microsatellite instability and immunohistochemistry for the prediction of germ-line MSH2 and MLH1 mutations in hereditary nonpolyposis colon cancer families. Cancer Res. 2002;62(12):3485-92.

 
498 - Muller W 2001 (2001)

Muller W, Burgart LJ, Krause-Paulus R, et al. The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC)--results of an international collaborative study. Fam Cancer. 2001;1(2):87-92.

 
499 - Weissman SM 2011 (2011)

Weissman SM, Bellcross C, Bittner CC, et al. Genetic counseling considerations in the evaluation of families for Lynch syndrome-a review. J Genet Couns. 2011;20(1):5-19.

 
500 - Rondagh (2013)

Rondagh EJ, Gulikers S, Gómez-García EB, et al. Nonpolypoid colorectal neoplasms: a challenge in endoscopic surveillance of patients with Lynch syndrome. Endoscopy. 2013;45(4):257-64. doi: 10.1055/s-0032-1326195. Epub 2013 Feb 25.

 
501 - Boparai KS (2010)
Boparai KS, Mathus-Vliegen EMH, Koornstra JJ, et al. Increased colorectal cancer risk during follow-up in patients with hyperplastic polyposis syndrome: a multicentre cohort study. Gut 2010;59:1094–100. doi:10.1136/gut.2009.185884
 
502 - Boparai KS (2010)
Boparai KS, Mathus-Vliegen EMH, Koornstra JJ, et al. Increased colorectal cancer risk during follow-up in patients with hyperplastic polyposis syndrome: a multicentre cohort study. Gut 2010;59:1094–100. doi:10.1136/gut.2009.185884
 
503 - Boparai KS (2010)
Boparai KS, Reitsma JB, Lemmens V, et al. Increased colorectal cancer risk in first-degree relatives of patients with hyperplastic polyposis syndrome. Gut 2010;59:1222–5. doi:10.1136/gut.2009.200741
 
504 - Boparai KS (2011)
Boparai KS, van den Broek FJC, van Eeden S, et al. Increased polyp detection using narrow band imaging compared with high resolution endoscopy in patients with hyperplastic polyposis syndrome. Endoscopy 2011;43:676–82. doi:10.1055/s-0030-1256447
 
505 - Boparai KS (2011)
Boparai KS, van den Broek FJC, van Eeden S, et al. Increased polyp detection using narrow band imaging compared with high resolution endoscopy in patients with hyperplastic polyposis syndrome. Endoscopy 2011;43:676–82. doi:10.1055/s-0030-1256447
 
506 - Cheah PY (2009)
Cheah PY, et al. Germline bone morphogenesis protein receptor 1A mutation causes colorectal tumorigenesis in hereditary mixed polyposis syndrome. Am J Gastroenterol. 2009 Dec;104(12):3027-3.
 
507 - Chow E (2006)
Chow E, Lipton L, Lynch E, et al. Hyperplastic polyposis syndrome: phenotypic presentations and the role of MBD4 and MYH. Gastroenterology 2006;131:30–9. doi:10.1016/S0739-5930(08)70068-0
 
508 - Chow E (2006)
Chow E, Lipton L, Lynch E, et al. Hyperplastic polyposis syndrome: phenotypic presentations and the role of MBD4 and MYH. Gastroenterology 2006;131:30–9. doi:10.1016/S0739-5930(08)70068-0
 
509 - Clendenning (2013)
Clendenning, et al. Germline Mutations in the Polyposis-Associated Genes BMPR1A, SMAD4, PTEN, MUTYH and GREM1 Are Not Common in Individuals with Serrated Polyposis Syndrome. PLoS One. 2013 Jun 21;8(6):e66705.
 
510 - Dekker E (2013)
Dekker E, van Leerdam M, Hazewinkel Y, et al. Nederlandse Richtlijn Coloscopie Surveillance. 2013.
 
511 - East JE (2008)

East JE, Saunders BP, Jass JR. Sporadic and Syndromic Hyperplastic Polyps and Serrated Adenomas of the Colon: Classification, Molecular Genetics, Natural History, and Clinical Management. Gastroenterol. Clin. North Am. 2008;37:25–46. doi:10.1016/j.gtc.2007.12.014

 
512 - East JE (2008)
East JE, Saunders BP, Jass JR. Sporadic and Syndromic Hyperplastic Polyps and Serrated Adenomas of the Colon: Classification, Molecular Genetics, Natural History, and Clinical Management. Gastroenterol. Clin. North Am. 2008;37:25–46. doi:10.1016/j.gtc.2007.12.014
 
513 - Edelstein (2012)
Edelstein, D. L.Axilbund JE, Griffin CA, Cruz-Correa M, et al. Serrated polyposis: rapid and relentless development of colorectal neoplasia. Gut. 2012. doi:10.1136/gutjnl-2011-300514
 
514 - Ferrandez A (2004)
Ferrandez A, Samowitz W, DiSario JA, et al. Phenotypic characteristics and risk of cancer development in hyperplastic polyposis: Case series and literature review. Am J Gastroenterol 2004;99:2012–8. doi:Doi 10.1111/J.1572-0241.2004.30021.X
 
515 - Gala MK (2014)
Gala MK, et al. Germline mutations in oncogene-induced senescence pathways are associated with multiple sessile serrated adenomas. Gastroenterology 2014;146:520-529
 
516 - Hazewinkel Y (2014)
Hazewinkel Y, et al. Yield of Screening Colonoscopy in First-degree Relatives of Patients With Serrated Polyposis Syndrome. J Clin Gastroenterol. 2014 Mar 6.
 
517 - Hazewinkel Y (2014)
Hazewinkel Y, Koornstra J-J, Boparai KS, et al. Yield of Screening Colonoscopy in First-degree Relatives of Patients With Serrated Polyposis Syndrome. J Clin Gastroenterol 2014;00:1–6. doi:10.1097/MCG.0000000000000103
 
518 - Hazewinkel Y (2014)
Hazewinkel Y, Tytgat KM a J, van Eeden S, et al. Incidence of Colonic Neoplasia in Patients with Serrated Polyposis Syndrome Who Undergo Annual Endoscopic Surveillance. Gastroenterology Published Online First: 20 March 2014. doi:10.1053/j.gastro.2014.03.015
 
519 - Hyman NH (2004)
Hyman NH, Anderson P, Blasyk H. Hyperplastic polyposis and the risk of colorectal cancer. Dis Colon Rectum 2004;47:2101–4. doi:10.1007/s10350-004-0709-6
 
520 - Hyman NH (2004)
Hyman NH, Anderson P, Blasyk H. Hyperplastic polyposis and the risk of colorectal cancer. Dis Colon Rectum 2004;47:2101–4. doi:10.1007/s10350-004-0709-6
 
521 - Jaeger E (2012)
Jaeger E, et al. Hereditary mixed polyposis syndrome is caused by a 40-kb upstream duplication that leads to increased and ectopic expression of the BMP antagonist GREM1. Nature Genetics 2012;44:699-703
 
522 - Jasperson KW (2013)
Jasperson KW, et al. Serrated polyposis: colonic phenotype, extracolonic features, and familial risk in a large cohort. Dis Colon Rectum. 2013 Nov;56(11):1211-6.
 
523 - Lage P (2004)
Lage P, Cravo M, Sousa R, et al. Management of Portuguese patients with hyperplastic polyposis and screening of at-risk first-degree relatives: a contribution for future guidelines based on a clinical study. Am J Gastroenterol 2004;99:1779–84. doi:10.1111/j.1572-0241.2004.30178.x
 
524 - Lucci-Cordisco (2013)
Lucci-Cordisco, et al. The growing complexity of the intestinal polyposis syndromes. Am J Med Genet 2013;161A:2777-2787
 
525 - Ngeow J (2013)
Ngeow J, et al. Prevalence of germline PTEN, BMPR1A, SMAD4, STK11 and ENG mutations in patients with moderate-load colorectal polyps. Gastroenterology, 2013;144:1402-1409.
 
526 - Oquiñena S (2013)
Oquiñena S, Guerra A, Pueyo A, et al. Serrated polyposis: prospective study of first-degree relatives. Eur J Gastroenterol Hepatol 2013;25:28–32. doi:10.1097/MEG.0b013e3283598506
 
527 - Oquiñena S (2013)
Oquiñena S. Serrated polyposis: prospective study of first-degree relatives. Eur J Gastroenterol Hepatol. 2013 Jan;25(1):28-32
 
528 - Orlowska J (2013)
Orlowska J. Serrated lesions and hyperplastic (serrated) polyposis relationship with colorectal cancer: classification and surveillance recommendations. Gastrointest Endosc 2013;77:858–71. doi:10.1016/j.gie.2013.02.016
 
529 - Rex DK (2012)
Rex DK, Ahnen DJ, Baron J a, et al. Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol 2012;107:1315–29; quiz 1314, 1330. doi:10.1038/ajg.2012.161
 
530 - Rex DK (2012)
Rex DK, Ahnen DJ, Baron J a, et al. Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol 2012;107:1315–29; quiz 1314, 1330. doi:10.1038/ajg.2012.161
 
531 - Rosty C (2013)
Rosty C, Hewett DG, Brown IS, et al. Serrated polyps of the large intestine: current understanding of diagnosis, pathogenesis, and clinical management. J Gastroenterol 2013;48:287–302. doi:10.1007/s00535-012-0720-y
 
532 - Snover DC (2010)
Snover DC, Ahnen DJ, Burt R. Serrated polyps of the colon and rectum and serrated polyposis; WHO classification of tumours of the digestive system. Lyon 2010;:160–5.
 
533 - Snover DC (2010)
Snover DC, Ahnen DJ, Burt R. Serrated polyps of the colon and rectum and serrated polyposis; WHO classification of tumours of the digestive system. Lyon 2010;:160–5.
 
534 - Vemulapalli KC (2012)
Vemulapalli KC, Rex DK. Failure to recognize serrated polyposis syndrome in a cohort with large sessile colorectal polyps. Gastrointest Endosc 2012;75:1206–10. doi:10.1016/j.gie.2012.01.033
 
535 - Whitelaw SC (1997)
Whitelaw SC, et al. Clinical and molecular features of the hereditary mixed polyposis syndrome. Gastroenterology 112, 327–334 (1997)
 
536 - Win AK (2012)
Win AK, Walters RJ, Buchanan DD, et al. Cancer risks for relatives of patients with serrated polyposis. Am J Gastroenterol 2012;107:770–8. doi:10.1038/ajg.2012.52
 
537 - Zorcolo L (2011)
Zorcolo L, et al. MUTYH-associated colon disease: adenomatous polyposis is only one of the possible phenotypes. A family report and literature review. Tumori. 2011 Sep-Oct;97(5):676-80
 
538 - Baglietto L 2010 (2010)

Baglietto L, et al. Risks of Lynch syndrome cancers for MSH6 mutation carriers. Journal of the National Cancer Institute, 2010. 102(3):193-201.

 
539 - Barrow E 2009 (2009)

Barrow E, et al. Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations. Clinical genetics, 2009. 75(2):41-9.

 
540 - Boilesen AE 2008 (2008)

Boilesen AE, Bisgaard ML, Bernstein I. Risk of gynecologic cancers in Danish hereditary non-polyposis colorectal cancer families. Acta obstetricia et gynecologica Scandinavica, 2008. 87(11): 1129-35.

 
541 - Bonadona V 2011 (2011)

Bonadona V, et al. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA : the journal of the American Medical Association, 2011. 305(22):2304-10.

 
542 - Borras E 2010 (2010)

Borras E, et al. MLH1 founder mutations with moderate penetrance in Spanish Lynch syndrome families. Cancer Res, 2010. 70(19):7379-91.

 
543 - Capelle LG 2010 (2010)

Capelle LG, et al. Risk and epidemiological time trends of gastric cancer in Lynch syndrome carriers in the Netherlands. Gastroenterology, 2010. 138(2):487-92.

 
544 - Dowty JG 2013 (2013)

Dowty JG, et al. Cancer risks for MLH1 and MSH2 mutation carriers. Human mutation, 2013. 34(3): p. 490-7.

 
545 - Kempers MJ 2011 (2011)

Kempers MJ, et al. Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study. The lancet oncology, 2011;12(1):49-55.

 
546 - Mukherjee B 2011 (2011)

Mukherjee B, et al. High risk of colorectal and endometrial cancer in Ashkenazi families with the MSH2 A636P founder mutation. Gastroenterology, 2011;140(7):1919-26.

 
547 - Ramsoekh D 2009 (2009)

Ramsoekh D, et al. Cancer risk in MLH1, MSH2 and MSH6 mutation carriers; different risk profiles may influence clinical management. Hereditary cancer in clinical practice, 2009. 7(1): p. 17.

 
548 - Senter L 2008 (2008)

Senter L. et al. The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. Gastroenterology, 2008;135(2):419-28.

 
549 - Steinke V 2011 (2011)

Steinke V, et al. Colorectal, endometrial and metachronous colorectalendometrial cancer risks in Lynch syndrome. Familial Cancer, 2011; 10: S31-S32.

 
550 - Stoffel E 2009 (2009)

Stoffel E, et al. Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome. Gastroenterology, 2009;37(5):1621-7.

 
551 - Talseth-Palmer BA 2010 (2010)

Talseth-Palmer BA. et al. MSH6 and PMS2 mutation positive Australian Lynch syndrome families: novel mutations, cancer risk and age of diagnosis of colorectal cancer. Hereditary cancer in clinical practice, 2010;8(1): 5.

 
552 - Therkildsen C 2012 (2012)

Therkildsen C, et al. Cancer risks and immunohistochemical profiles linked to the Danish MLH1 Lynch syndrome founder mutation. Familial cancer, 2012; 11(4): 579-85.

 
553 - van der Post RS 2010 (2010)

van der Post RS, et al. Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers. Journal of medical genetics, 2010; 47(7):464-70.

 
554 - Watson P 2008 (2008)

Watson P, et al. The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome. Int J Cancer, 2008;123(2): 444-9.

 
555 - Wijnen JT 2011 (2011)

Wijnen JT, et al. Cancer risk in Lynch syndrome families diagnosed with a PMS2 mutation. Familial Cancer, 2011;10: S7.

 
556 - Stuckless S 2013 (2013)

Stuckless S, et al. Impact of gynecological screening in Lynch syndrome carriers with an MSH2 mutation. Clinical genetics, 2013. 83(4):359-64.

 
557 - Evans DG 2009 (2009)

Evans DG, et al. Risk-reducing surgery for ovarian cancer: outcomes in 300 surgeries suggest a low peritoneal primary risk. Eur J Hum Genet. 2009 Nov;17(11):1381-5

 
558 - Schmeler KM 2006 (2006)

Schmeler KM, Lynch HT, Chen LM, et al. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med. 2006 Jan 19;354(3):261-9.

 
559 - Madalinska JB 2006 (2006)

Madalinska JB, van Beurden M, Bleiker EM, et al. The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy. J Clin Oncol. 2006 Aug 1;24(22):3576-82.

 
560 - Lu KH. 2007 (2008)

Lu KH. Hereditary gynecologic cancers: differential diagnosis, surveillance, management and surgical prophylaxis. Fam Cancer. 2008;7(1):53-8. Epub 2007 Jul 17

 
561 - Genta RM 2002 (2002)

Genta RM. Review article: after gastritis--an imaginary journey into a Helicobacter-free world. Aliment Pharmacol Ther. 2002 Jul;16 Suppl 4:89-94.

 
562 - Parsonnet J 1995 (1995)

Parsonnet J. The incidence of Helicobacter pylori infection. Aliment Pharmacol Ther. 1995;9 Suppl 2:45-51.

 
563 - Uemura N 2001 (2001)

Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of

gastric cancer. N Engl J Med. 2001 Sep 13;345(11):784-9.

 
564 - Vasen HF 2013 (2012)

Vasen HF, Blanco I, Aktan-Collan K, et al. Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts. Gut. 2013 Jun;62(6):812-23. doi: 10.1136/gutjnl-2012-304356. Epub 2013 Feb 13.

 
565 - Chou R 2010 (2010)

Chou R, Dana T. Screening adults for bladder cancer: a review of the evidence for the U.S. preventive services task force. Ann Intern Med. 2010 Oct 5;153(7):461-8.

 
566 - Vitellaro M 2014 (2014)

Vitellaro M, Sala P, Signoroni S, Radice P, et al. Risk of desmoid tumours after open and laparoscopic colectomy in patients with familial adenomatous polyposis. Br J Surg. 2014 Apr;101(5):558-65.

 
567 - Aretz S 2007 (2008)

Aretz S, Stienen D, Friedrichs N, et al. Somatic APC mosaicism: a frequent cause of familial adenomatouspolyposis (FAP). Hum Mutat. 2007 Oct;28(10):985-92. PubMed PMID: 17486639

 
568 - Filipe B 2009 (2009)

Filipe B, Albuquerque C, Bik E, et al. APC somatic mosaicism in a patient with Gardner syndrome carrying the E1573X mutation: report of a case. Dis Colon Rectum. 2009 Aug;52(8):1516-20; discussion 1520-1. doi: 10.1007/DCR.0b013e3181ab810f. PubMed PMID: 19617769

 
569 - Hes FJ 2007 (2008)

Hes FJ, Nielsen M, Bik EC, et al. Somatic APC mosaicism: an underestimated cause of polyposis coli. Gut. 2008 Jan;57(1):71-6. Epub 2007 Jun 29. PubMed PMID: 17604324

 
570 - Necker J 2011 (2011)

Necker J, Kovac M, Attenhofer M,et al. Detection of APC germ line mosaicism in patients with de novo familial adenomatous polyposis: a plea for the protein truncation test. J Med Genet. 2011 Aug;48(8):526-9. doi: 10.1136/jmg.2011.089474. Epub 2011 Jun 7. PubMed PMID: 21653199

 
571 - Mongin C 2012 (2011)

Mongin C, Coulet F, Lefevre JH, et al. Unexplained polyposis: a challenge for geneticists, pathologists and gastroenterologists. Clin Genet. 2012 Jan;81(1):38-46. doi:10.1111/j.1399-0004.2011.01676.x. Epub 2011 May 4. PubMed PMID: 21476993

 
572 - Schwab AL 2007 (2008)

Schwab AL, Tuohy TM, Condie M, et al. Gonadal mosaicism and familial adenomatous polyposis. Fam Cancer. 2008;7(2):173-7. Epub 2007 Nov 18. PubMed PMID: 18026870

 
573 - Bartels SA 2014 (2014)

Bartels SA, Vlug MS, Hollmann MW, et al. Collaborative LAFA Study Group. Small bowel obstruction, incisional hernia and survival after laparoscopic and open colonic re http://www.ncbi.nlm.nih.gov/pubmed/?term=Bartels+Br+J+Surg+2014%3B+101%3A+1153-9section (LAFA study). Br J Surg. 2014 Aug;101(9):1153-9. doi: 10.1002/bjs.9585. Epub 2014 Jun 30.

 
574 - Bartels SA (2012)

Bartels SA, DʼHoore A, Cuesta MA, et al. Significantly increased pregnancy rates after laparoscopic restorative proctocolectomy: a cross-sectional study. Ann Surg. 2012 Dec;256(6):1045-8. doi: 10.1097/SLA.0b013e318250caa9.#

 
575 - Koskenvuo L 2014 (2014)

Koskenvuo L, Renkonen-Sinisalo L, Järvinen HJ, Lepistö A. Risk of cancer and secondary proctectomy after colectomy and ileorectal anastomosis in familial adenomatous polyposis. Int J Colorectal Dis. 2014 Feb;29(2):225-30

 
576 - Sinha A 2010 (2010)

Sinha A, Tekkis PP, Rashid S, Phillips RK, Clark SK. Risk factors for secondary proctectomy in patients with familial adenomatous polyposis. Br J Surg. 2010;97(11):1710-5.

 
577 - Schiessling S 2013 (2013)

Schiessling S, Leowardi C, Kienle P, Antolovic D, Knebel P, Bruckner T, Kadmon M, Seiler CM, Büchler MW, Diener MK, Ulrich A. Laparoscopic versus conventional ileoanal pouch procedure in patients undergoing elective restorative proctocolectomy (LapConPouch Trial)-a randomized controlled trial. Langenbecks Arch Surg. 2013;398(6):807-16.

 
578 - Knudsen AL 2010 (2010)

Knudsen AL, Bülow S, Tomlinson I, Möslein G, Heinimann K, Christensen IJ; AFAP Study Group. Attenuated familial adenomatous polyposis: results from an international collaborative study. Colorectal Dis. 2010 Oct;12(10 Online):e243-9.

 
579 - Nieuwenhuis MH 2011 (2011)

Nieuwenhuis MH, Lefevre JH, Bülow S Family history, surgery, and APC mutation are risk factors for desmoid tumors in familial adenomatous polyposis: an international cohort study. Dis Colon Rectum. 2011 Oct;54(10):1229-34. doi: 10.1097/DCR.0b013e318227e4e8,

 
580 - Nieuwenhuis MH 2011 (2010)

Nieuwenhuis MH, Mathus-Vliegen EM, Baeten CG, Evaluation of management of desmoid tumours associated with familial adenomatous polyposis in Dutch patients. Br J Cancer. 2011 Jan 4;104(1):37-42. doi: 10.1038/sj.bjc.6605997. Epub 2010 Nov 9.

 
581 - von Roon AC 2011 (2011)

von Roon AC, Will OC, Man RF, et al. Mucosectomy with handsewn anastomosis reduces the risk of adenoma formation in the anorectal segment after restorative proctocolectomy for familial adenomatous polyposis. Ann Surg. 2011 Feb;253(2):314-7. doi: 10.1097/SLA.0b013e318f3f498.

 
582 - Tajika M (2013)

Tajika M, Niwa Y, Bhatia V, Tanaka T, Ishihara M, Yamao K. Risk of ileal pouch neoplasms in patients with familial adenomatous polyposis. World J Gastroenterol. 2013 Oct 28;19(40):6774-83.

 
583 - Sinha A, 2010 (2010)

Sinha A, Tekkis PP, Rashid S, Phillips RK, Clark SK. Risk factors for secondary proctectomy in patients with familial adenomatous polyposis.Br J Surg. 2010 Nov;97(11):1710-5.

 
584 - Friederich P 2008 (2008)

Friederich P, de Jong AE, Mathus-Vliegen LM, Dekker E, Krieken HH, Dees J, Nagengast FM, Vasen HF. Risk of developing adenomas and carcinomas in the ileal pouch in patients with familial adenomatous polyposis.Clin Gastroenterol Hepatol. 2008 Nov;6(11):1237-42

 
585 - West NJ, 2010 (2010)

West NJ, Clark SK, Phillips RK, et al. Eicosapentaenoic acid reduces rectal polyp number and size in familial adenomatous polyposis. Gut. 2010 Jul;59(7):918-25.

 
586 - Vennix S 2014 (2014)

 Vennix S, Pelzers L, Bouvy N, et al. Laparoscopic versus open total mesorectal excision for rectal cancer. Cochrane Database Syst Rev. 2014 Apr 15;4:CD005200. doi: 10.1002/14651858.CD005200.pub3.

 
587 - Vitellaro M 2014 (2014)

Vitellaro M, Sala P, Signoroni S, Radice P, et al. Risk of desmoid tumours after open and laparoscopic colectomy in patients with familial adenomatous polyposis. Br J Surg. 2014 Apr;101(5):558-65

 
588 -  Skipworth JR 2011 (2011)

 Skipworth JR, Morkane C, Raptis DA, et al. Pancreaticoduodenectomy for advanced duodenal and ampullary adenomatosis in familial adenomatous polyposis. HPB (Oxford). 2011 May;13(5):342-9

 
589 - Alderlieste YA 2013 (2013)

Alderlieste YA, Rauws EA, Mathus-Vliegen EM, Fockens P, Dekker E.Prospective enteroscopic evaluation of jejunal polyposis in patients with familial adenomatous polyposis and advanced duodenal polyposis.Fam Cancer. 2013 Mar;12(1):51-6.

 
590 - Ruys AT 2010 (2010)

Ruys AT, Alderlieste YA, Gouma DJ, Dekker E, Mathus-Vliegen EM .Jejunal cancer in patients with familial adenomatous polyposis. Clin Gastroenterol Hepatol. 2010 Aug;8(8):731-3.

 
591 - de Castro SmM 2008 (2008)

de Castro SM, van Eijck CH, Rutten JP, et al. Pancreas-preserving total duodenectomy versus standard pancreatoduodenectomy for patients with familial adenomatous polyposis and polyps in the duodenum. Br J Surg. 2008 Nov;95(11):1380-6. doi: 10.1002/bjs.6308.

 
592 - van Heumen BW 2012 (2012)

van Heumen BW, Nieuwenhuis MH, van Goor H, et al. Surgical management for advanced duodenal adenomatosis and duodenal cancer in Dutch patients with familial adenomatous polyposis: a nationwide retrospective cohort study. Surgery. 2012 May;151(5):681-90.

 
593 - Grover S 2012 (2012)

Grover S, Kastrinos F, Steyerberg EW, et al. Prevalence and phenotypes of APC and MUTYH mutations in patients with multiple colorectal adenomas. JAMA. 2012 Aug 1;308(5):485-92.

 
594 - Hes FJ, 2008 (2008)

Hes FJ, Nielsen M, Bik EC, et al.. Somatic APC mosaicism: an underestimated cause of polyposis coli. Gut. 2008 Jan;57(1):71-6.

 
595 - Palles C 2013 (2013)

Palles C, Cazier JB, Howarth KM, et al. Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas. Nat Genet. 2013 Feb;45(2):136-44

 
596 - Valle L 2014 (2014)

Valle L, Hernández-Illán E, Bellido F, et al. New insights into POLE and POLD1 germline mutations in familial colorectal cancer and polyposis. Hum Mol Genet. 2014 Jul 1;23(13):3506-12.

 
597 - Aretz S (2000)

Aretz S, Stienen D, Friedrichs N, Stemmler S, et al. Somatic APC mosaicism: a frequent cause of familial adenomatous polyposis (FAP). Hum Mutat 28(10):985-92.

 
598 - Al-Tassan N 2002 (2002)

Al-Tassan N, Chmiel NH, Maynard J, et al. Inherited variants of MYH associated with somatic G:C-->T:A mutations in colorectal tumors. Nat Genet. 2002 Feb;30(2):227-32. Epub 2002 Jan 30.

 
599 - Aretz 2006 (2006)

Aretz et al, MUTYH-associated polyposis: 70 of 71 patients with biallelic mutations present with an attenuated or atypical phenotype. Int J Cancer. 2006 Aug 15;119(4):807-14.

 
600 - Brand R 2012 (2012)

 Brand R, Nielsen M, Lynch H, et al. MUTYH-Associated Polyposis. 2012 Oct 4. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2015. Available from: http://www.ncbi.nlm.nih.gov/books/NBK107219/?report=classic

 
601 - Cleary SP 2009 (2008)

Cleary SP, Cotterchio M, Jenkins MA, Kim H, Bristow R, Green R, Haile R, Hopper JL, LeMarchand L, Lindor N, Parfrey P, Potter J, Younghusband B, Gallinger S. Germline MutY human homologue mutations and colorectal cancer: a multisite case-control study. Gastroenterology. 2009 Apr;136(4):1251-60. doi: 10.1053/j.gastro.2008.12.050. Epub 2008 Dec 27.

 
602 - Win AK 2014 (2014)

Win AK, Dowty JG, Cleary SP, et al. Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancer. Gastroenterology. 2014 May;146(5):1208-11.e1-5. doi: 10.1053/j.gastro.2014.01.022. Epub 2014 Jan 17

 
603 - Nielsen 2009 (2009)

Nielsen M, Joerink-van de Beld MC, Jones N, et al. Analysis of MUTYH genotypes and colorectal phenotypes in patients With MUTYH-associated polyposis. Gastroenterology. 2009 Feb;136(2):471-6.

 
604 - Nielsen 2010 (2010)

Nielsen M1, Morreau H, Vasen HF, et al, MUTYH-associated polyposis (MAP). Crit Rev Oncol Hematol. 2011 Jul;79(1):1-16. doi: 10.1016/j.critrevonc.2010.05.011. Epub 2010 Jul 21.

 

 

 
605 - Nielsen M 2009 (2008)

Nielsen M, Joerink-van de Beld MC, Jones N, et al . Analysis of MUTYH genotypes and colorectal phenotypes in patients With MUTYH-associated polyposis. Gastroenterology. 2009 Feb;136(2):471-6. doi: 10.1053/j.gastro.2008.10.056. Epub 2008 Oct 30

 
606 - Nielsen M 2007 (2008)

Nielsen M, Hes FJ, Nagengast FM et al. Germline mutations in APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis. Clin Genet. 2007 May;71(5):427-33.

 
607 - Nielsen M 2007 (2008)

Nielsen M, Hes FJ, Vasen HF, et al. Cost-utility analysis of genetic screening in families of patients with germline MUTYH mutations. BMC Med Genet. 2007 Jul 2;8:42,

 
608 - Nieuwenhuis MH 2012 (2010)

Nieuwenhuis MH, Vogt S, Jones N, et al. Evidence for accelerated colorectal adenoma--carcinoma progression in MUTYH-associated polyposis? Gut. 2012 May;61(5):734-8. doi: 10.1136/gut.2010.229104. Epub 2011 Aug 16

 
609 - van Puijenbroek M 2008 (2008)

van Puijenbroek M, Nielsen M, Tops CM, et al. Identification of patients with (atypical) MUTYH-associated polyposis by KRAS2 c.34G > T prescreening followed by MUTYH hotspot analysis in formalin-fixed paraffin-embedded tissue. Clin Cancer Res. 2008 Jan 1;14(1):139-42. doi: 10.1158/1078-0432.CCR-07-1705,

 
610 - Zhang Y 2006 (2006)

Zhang Y, Newcomb PA, Egan KM, et al. Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):353-8.

 
611 - Beiner ME 2009 (2009)

Beiner ME, Zhang WW, Zhang S, et al. Mutations of the MYH gene do not substantially contribute to the risk of breast cancer. Breast Cancer Res Treat. 2009 Apr;114(3):575-8. doi: 10.1007/s10549-008-0042-1. Epub 2008 May 4.

 
612 - Nielsen M 2009 (2009)

Nielsen M, de Miranda NF, van Puijenbroek M, et al. Colorectal carcinomas in MUTYH-associated polyposis display histopathological similarities to microsatellite unstable carcinomas. BMC Cancer. 2009 Jun 15;9:184. doi: 10.1186/1471-2407-9-184.

 
613 - Croitoru ME 2004 (2004)

Croitoru ME, Cleary SP, Di Nicola N, et al. Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk. J Natl Cancer Inst. 2004 Nov 3;96(21):1631-4.#

 
614 - Wang L 2004 (2004)

Wang L, Baudhuin LM, Boardman LA, et al. MYH mutations in patients with attenuated and classic polyposis and with young-onset colorectal cancer without polyps. Gastroenterology. 2004 Jul;127(1):9-16.#

 
615 - Balaguer F 2007 (2008)

Balaguer F, Castellví-Bel S, Castells A, et al. Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Identification of MYH mutation carriers in colorectal cancer: a multicenter, case-control, population-based study. Clin Gastroenterol Hepatol. 2007 Mar;5(3):379-87.

 
616 - Fleischmann C 2004 (2004)

Fleischmann C, Peto J, Cheadle J, et al. Comprehensive analysis of the contribution of germline MYH variation to early-onset colorectal cancer. Int J Cancer. 2004 Apr 20;109(4):554-8.#

 
617 - Grünhage F 2008 (2008)

Grünhage F, Jungck M, Lamberti C, et al. Contribution of common monoallelic MUTYH gene variants in German patients with familial colorectal cancer. Cancer Biomark. 2008;4(2):55-61.

 
618 - Avezzu A 2008 (2008)

Avezzù A, Agostini M, Pucciarelli S, et al. The role of MYH gene in genetic predisposition to colorectal cancer: another piece of the puzzle. Cancer Lett. 2008 Sep 18;268(2):308-13. doi: 10.1016/j.canlet.2008.04.004. Epub 2008 May 20.#

 
619 - Giardiello FM 1993 (1993)

Giardiello FM, Offerhaus GJ, Lee DH, et al. Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis. Gut. 1993 Oct;34(10):1394-6.

 
620 - Plail RO 1987 (1987)

Plail RO, Bussey HJ, Glazer G, et al. Adenomatous polyposis: an association with carcinoma of the thyroid. Br J Surg, 1987,74(5):377-80

 
621 - Bulow C1997 (1997)

Bulow C, Bulow S. Is screening for thyroid carcinoma indicated in familial adenomatous polyposis? The Leeds Castle Polyposis Group. Int J Colorectal Dis. 1997;12(4):240-2.

 
622 - Hizawa K 1997 (1997)

Hizawa K, Iida M, Aoyagi K, et al. Thyroid neoplasia and familial adenomatous polyposis/Gardner's syndrome. J Gastroenterol,1997.32(2):196-9.

 
623 - Perrier 1998 (1998)

Perrier ND, van Heerden JA, Goellner JR, et al. Thyroid cancer in patients with familial adenomatous polyposis. World J Surg, 1998; 22(7):738-42; discussion 743.

 
624 - Truta B 2003 (2003)

Truta B, Allen BA, Conrad PG et al. Genotype and phenotype of patients with both familial adenomatous polyposis and thyroid carcinoma. Fam Cancer, 2003. 2(2):95-9.

 
625 - van der Linde, K 1998 (1998)

van der Linde K, Vasen HF, van Vliet AC. Occurrence of thyroid carcinoma in Dutch patients with familial adenomatous polyposis. An epidemiological study and report of new cases. Eur J Gastroenterol Hepatol. 1998 Sep;10(9):777-81.

 
626 - Herraiz M 2007 (2008)

Herraiz M, Barbesino G, Faquin W,  et al. Prevalence of thyroid cancer in familial adenomatous polyposis syndrome and the role of screening ultrasound examinations. Clin Gastroenterol Hepatol, 2007; 5(3):367-73.

 
627 - Steinhagen E 2012 (2012)

Steinhagen E, Guillem JG, Chang G, et al. The prevalence of thyroid cancer and benign thyroid disease in patients with familial adenomatous polyposis may be higher than previously recognized. Clin Colorectal Cancer, 2012.11(4):304-8.

 
628 - Bulow S 1988 (1988)

Bulow S, Holm NV, Mellemgaard A. Papillary thyroid carcinoma in Danish patients with familial adenomatous polyposis. Int J Colorectal Dis, 1988.3(1):29-31.

 
629 - Jarrar AM 2011 (2011)

Jarrar AM, Milas M, Mitchell J, et al. Screening for thyroid cancer in patients with familial adenomatous polyposis. Ann Surg, 2011; 253(3): 515-21 .

 
630 - Ito Y 2011 (2011)

Ito Y., et al. Our experience of treatment of cribriform morular variant of papillary thyroid carcinoma; difference in clinicopathological features of FAP-associated and sporadic patients. Endocr J, 2011;58(8):685-9

 
631 - Tomoda C 2004 (2004)

Tomoda C, Miyauchi A, Uruno T et al. Cribriform-morular variant of Papillary Thyroid Carcinoma: Clue to Early Detection of Familial Adenomatous Polyposis-associated Colon Cancer. World J Surg. 2004 Sep;28(9):886-9.

 
632 - Vogt S 2009 (2009)

Vogt S, Jones N, Christian D, et al. Expanded extracolonic tumor spectrum in MUTYH-associated polyposis. Gastroenterology, 2009;137(6):1976-85 e1-10.

 
633 - Cetta F 1998 (1998)

Cetta F, Olschwang S, Petracci M, et al. Genetic alterations in thyroid carcinoma associated with familial adenomatous polyposis: clinical implications and suggestions for early detection. World J Surg, 1998;22(12):1231-6.

 
634 - Chong Y 2013 (2013)

Chong Y, Shin JH, Oh YL, et al. Cribriform-Morular Variant of Papillary Thyroid Carcinoma: Ultrasonographic and Clinical Characteristics. Thyroid, 2013; 23(1):45-9

 
635 - Harach HR 2003 (2003)

Harach HR. Familial adenomatous polyposis associated with sporadic MEN 1 and thyroid carcinoma related to APC mutation. Am J Surg Pathol, 2003;27(3):412-3.

 
636 - Cameselle-Teijeiro J 1999 (1999)

Cameselle-Teijeiro J, Chan JK. Cribriform-morular variant of papillary carcinoma: a distinctive variant representing the sporadic counterpart of familial adenomatous polyposis-associated thyroid carcinoma? Mod Pathol. 1999 Apr;12(4):400-11.

 
637 - Levy RA, (2014)

Levy RA, Hui VW, Sood R et al. Cribriform-morular variant of papillary thyroid carcinoma: an indication to screen for occult FAP. Fam Cancer. 2014 Dec;13(4):547-51.

 
638 - Fenton PA 2001 (2001)

Fenton PA,  Clarke SE, Owen Wet al. Cribriform variant papillary thyroid cancer: a characteristic of familial adenomatous polyposis. Thyroid, 2001;11(2):193-7

 
639 - Iwama T 1993 (1993)

Iwama T, Mishima Y, Utsunomiya J. The impact of familial adenomatous polyposis on the tumorigenesis and mortality at the several organs. Its rational treatment. Ann Surg. 1993 Feb;217(2):101-8..

 
640 - Cetta F 2000 (2000)

Cetta F, Montalto G, Gori M, et al. Germline mutations of the APC gene in patients with familial adenomatous polyposis-associated thyroid carcinoma: results from a European cooperative study. J Clin Endocrinol Metab. 2000 Jan;85(1):286-92.

 
641 - Kennedy RD 2014 (2014)

Kennedy RD, Potter DD, Moir CR, et al. The natural history of familial adenomatous polyposis syndrome: a 24 year review of a single center experience in screening, diagnosis, and outcomes. J Pediatr Surg. 2014 Jan;49(1):82-6.

 
642 - Soravia C 1999 (1999)

Soravia C, Sugg SL, Berk T, et al., Familial adenomatous polyposis-associated thyroid cancer: a clinical, pathological, and molecular genetics study.  Am J Pathol. 1999 Jan;154(1):127-35.

 
643 - Civitelli S 1996 (1996)

Civitelli S, Tanzini G, Cetta F, et al., Papillary thyroid carcinoma in three siblings with familial adenomatous polyposis. Int J Colorectal Dis. 1996;11(1):34-7.

 
644 - Delamarre J 1988. (1988)

Delamarre J, Capron JP, Armand A, et al., Thyroid carcinoma in two sisters with familial polyposis of the colon. Case reports and review of the literature. J Clin Gastroenterol. 1988 Dec;10(6):659-62.

 
645 - Kashiwagi H 1996 (1996)

Kashiwagi H, Konishi F, Kanazawa K, et al., Sisters with familial adenomatous polyposis affected with thyroid carcinoma, desmoid tumour and duodenal polyposis. Br J Surg. 1996 Feb;83(2):228.

 
646 - Kameyama K 2001 (2001)

Kameyama K, Takami H. FAP associated thyroid carcinoma in mother and her daughter. Fam Cancer. 2001;1(2):83-6.

 
647 - Steinhagen E 2014 (2014)

Steinhagen E, Hui VW, Levy RA, et al., Results of a prospective thyroid ultrasound screening program in adenomatous polyposis patients. Am J Surg. 2014 Nov;208(5):764-9.